How do you start a hospice care agency business in 2027?

TL;DR: Starting a hospice care agency business in 2027 (a.k.a. Medicare-certified hospice, hospice agency, end-of-life care provider, terminal care agency, or palliative end-of-life service) — the Medicare-certified interdisciplinary-team (IDT) home-and-facility-based end-of-life care agency providing palliative pain + symptom management, nursing, social work, chaplaincy, home health aide, volunteer, and bereavement services to patients certified by two physicians to have a terminal prognosis of six months or less if the disease runs its normal course, delivered under the Medicare Hospice Benefit established by the 1982 Tax Equity and Fiscal Responsibility Act (TEFRA) and codified at 42 CFR 418 Conditions of Participation, monetized through four Medicare per-diem levels (Routine Home Care ~$215/day, Continuous Home Care ~$1,710/day, Inpatient Respite ~$510/day, General Inpatient ~$1,180/day) subject to an aggregate annual Medicare Cap ~$35K per patient and the Hospice Quality Reporting Program (HQRP) with HIS + CAHPS + HCI quality measures publicly reported on Care Compare — means navigating CMS-855A enrollment plus state Department of Health hospice licensing plus accreditation by CHAP (Community Health Accreditation Partner), ACHC (Accreditation Commission for Health Care), or The Joint Commission (TJC) plus 17 states still operating Certificate of Need (CON) for hospice plus the federal anti-fraud apparatus (DOJ + OIG + UPIC + PEPPER + TPE) that has recovered $3B+ in hospice False Claims Act settlements 2010-2024, and operating against a US universe of ~5,800 Medicare-certified hospices serving ~1.7M Medicare beneficiaries annually (~51% of all Medicare decedents elect hospice) with average length of stay 90-95 days and median 18 days per MedPAC + NHPCO — capturing typical mature 100-ADC (average daily census) hospice revenue $8M-$12M and 12-22% EBITDA margins (much healthier than SNF/HHA because of per-diem reimbursement + lighter capital + lower lawsuit exposure) with named comps including VITAS Healthcare (Chemed Corporation NYSE: CHE — largest US hospice, ~50,000 ADC), Amedisys (NASDAQ: AMED — acquired by Optum/UnitedHealth 2024 deal pending FTC review), Encompass Health (NYSE: EHC) / Enhabit (NYSE: EHAB — spun off 2022), Compassus (Audax + TowerBrook PE), Bristol Hospice (Webster Equity Partners), Pennant Group (NASDAQ: PNTG — Ensign Group spinoff), Curo Health Services (Humana CenterWell), Heart 'n Home Hospice, Hospice of the Valley (largest nonprofit), AccentCare (Advent International), HouseWorks (Audax), Aveanna (NASDAQ: AVAH), LHC Group (UnitedHealth/Optum acquired 2023) — with PE/strategic consolidation rolling up hospice platforms at 10-14x EBITDA for stabilized multi-state operators and 6-9x for single-state. The hardest part is Medicare audit exposure (UPIC + ZPIC + TPE + RAC + OIG audits + qui tam DOJ False Claims Act actions recovered $3B+ 2010-2024 with VITAS paying $75M+ in settlements) plus length-of-stay scrutiny (long-stay patients + live discharges trigger audit flags) plus PEPPER report comparative analytics plus 17-state CON barrier plus RN labor crisis ($80-$120K hospice RN with 35-55% turnover) plus referral-source dependency (60-75% from hospital + SNF/AL discharge + oncology + geriatrics) plus FAST 7C dementia eligibility ambiguity plus HCI Hospice Care Index underperformance Medicare penalties, not the capital stack.

> ### 🎯 Bottom Line > - [Capital] $185K-$485K to STARTUP a new Medicare-certified hospice in non-CON states (working capital + license + accreditation + initial staff + payroll runway + EMR + insurance); $485K-$1.5M for CON-state new entry plus consulting + competing applications; $1.5M-$8M to ACQUIRE existing operating hospice with active Medicare provider number + ~50-150 ADC census + accreditation + referral relationships (multiple of 0.8-1.5x annual revenue OR 6-10x EBITDA depending on payer mix + ADC + survey history); expect 12-24 months for de novo CMS Medicare certification (CMS-855A application + state DOH license + initial accreditation survey + first patient admission within 6 months of CMS approval + initial Medicare survey at 6-month mark validating CoP compliance under 42 CFR 418) and 6-18 months for CHOW (change of ownership) acquisition with provisional billing; hospice is dramatically lower capital than SNF/AL/MC because care delivered in patient's home/SNF/AL rather than purpose-built facility (only general inpatient unit if equipped requires real estate). > - [Margins] Mature stabilized 100-ADC hospice generates $8M-$12M annual revenue with 12-22% EBITDA margins ($960K-$2.6M EBITDA) — meaningfully healthier than SNF/HHA because of stable per-diem reimbursement (Medicare RHC ~$215/day baseline pays for IDT regardless of services delivered that day = high contribution margin once IDT loaded), lighter capital (no purpose-built real estate beyond optional GIP unit), lower lawsuit exposure than SNF (terminal patients = limited damages framework), and lower labor intensity than SNF (RN case manager 1:12-1:15 ratio vs SNF RN 1:20 on shift but with full IDT support); payer mix typically 88-94% Medicare Hospice Benefit (per-diem RHC ~$215/day dominant ~98% of days, CHC ~$1,710/day rare ~0.2%, IRC ~$510/day occasional ~0.3%, GIP ~$1,180/day occasional ~1.5%) + 3-8% Medicaid hospice (state-by-state per-diem mirrors Medicare in most states) + 1-3% commercial + private pay, with the Medicare Cap (~$35K per patient per year aggregate) the key constraint on long-stay/dementia-heavy operators. > - [Hardest part] Medicare audit exposure + length-of-stay scrutiny + qui tam DOJ False Claims Act + 17-state CON barrier + RN labor + referral dependency, not occupancy demand — DOJ recovered $3B+ in hospice False Claims Act settlements 2010-2024 with VITAS paying $75M+ across multiple settlements, AseraCare $1B settlement reversed on appeal but legacy lives on, Chemed/Roto-Rooter $75M, Hospice of Cincinnati $19M, Halifax Health $85M — federal audit apparatus includes UPIC (Unified Program Integrity Contractor) + ZPIC + TPE (Targeted Probe and Educate) + RAC (Recovery Audit Contractor) + OIG (Office of Inspector General) + DOJ + qui tam whistleblower False Claims Act actions with PEPPER (Program for Evaluating Payment Patterns Electronic Report) and HCI (Hospice Care Index) comparative analytics flagging length-of-stay outliers + live discharge rates + GIP utilization + non-cancer diagnosis patterns, and the FAST 7C dementia eligibility ambiguity (Functional Assessment Staging Tool stage 7C is the Medicare hospice eligibility threshold for Alzheimer's/dementia but is clinically ambiguous and the #1 audit target), plus 17 CON states still gate hospice entry (NY, NC, GA, TN, KY, WV, VA, MS, AL, SC, MD, DC, CT, RI, ME, VT, NH, HI), RN labor crisis ($80-$120K hospice RN with 35-55% turnover), 60-75% referral dependency on hospital discharge planners + oncology + geriatrics + SNF/AL/HHA = losing 1-2 referral sources collapses census, and the 2024 HCI Hospice Care Index linking quality measures to Medicare payment with underperformance penalties up to 2% of Medicare revenue.

A hospice care agency in 2027 is a Medicare-certified interdisciplinary-team home-and-facility-based end-of-life care provider delivering palliative pain + symptom management, nursing, social work, chaplaincy, home health aide, volunteer, and 13-month bereavement services under the Medicare Hospice Benefit (established 1982 TEFRA, codified 42 CFR 418) to patients certified by two physicians with terminal prognosis of six months or less. Structurally distinct from palliative care (q9620 adjacent — not necessarily terminal, often concurrent with curative treatment, billed under Medicare Part B physician fees + facility fees rather than per-diem), home health agency HHA (q9630 adjacent — Medicare-certified skilled home care for non-terminal patients, intermittent visit-based reimbursement), skilled nursing facility SNF (q9655 — residential 24/7 RN-supervised, completely different model), assisted living AL (q9650 — social model), memory care MC (q9653), adult day care ADC (q9652), inpatient hospice unit (GIP within hospital or freestanding IPU — Medicare GIP per-diem ~$1,180/day for acute symptom management), and LTACH/IRF (post-acute hospitals). Hospice is uniquely per-diem paid regardless of intensity with 4 Medicare levels of care (RHC routine, CHC continuous, IRC respite, GIP general inpatient) plus aggregate Medicare Cap (~$35K/patient/year).

The honest 2027 demand reality — ~5,800 Medicare-certified hospices in the US serving ~1.7M Medicare beneficiaries annually (~51% of all Medicare decedents elect hospice) with average length of stay (ALOS) 90-95 days and median LOS only 18 days (long-tail-driven by FAST 7C dementia patients = 6-24+ months) per MedPAC + NHPCO (National Hospice and Palliative Care Organization). Demand drivers: 75+ population growing from ~24M (2024) to ~45M by 2040 per US Census Bureau; 65+ population growing from ~58M (2024) to ~80M by 2040; Medicare hospice election rate growing from ~22% (2000) to ~51% (2024) with continued growth runway; hospital + SNF + AL + HHA + oncology + geriatrics + cardiology + palliative care referral pipeline driving admissions; Medicare Advantage hospice carve-in pilot (VBID Value-Based Insurance Design Model) that expired December 2024 (mostly carved-out again 2025+); state-by-state penetration varies 35-65% with Sun Belt (FL, AZ, UT, AR) historically high penetration and Northeast (NY, MA, NJ) historically low. Patient mix typically ~70% cancer + cardiopulmonary (COPD/CHF) + neurological + renal (clear prognosis, shorter LOS) + ~30% dementia + adult failure-to-thrive (FTT) + frailty (ambiguous prognosis, longer LOS — and the audit flag zone).

The five things that determine whether a hospice operator survives years 1-3: (1) Medicare audit posture + length-of-stay discipline + PEPPER report standing — DOJ has recovered $3B+ in hospice FCA settlements; operators with high long-stay % + high live-discharge % + heavy dementia/FTT diagnosis + GIP under-utilization face UPIC + TPE + ADR (Additional Documentation Request) + payment recoupment + corporate integrity agreement (CIA) risk; (2) Referral pipeline — hospital discharge planners + oncology + SNF/AL/HHA + community physicians — 60-75% of admissions flow through 5-15 referral sources; losing 1-2 referral sources collapses census within 30-60 days; (3) IDT staffing — RN case manager + MSW + chaplain + HHA + volunteer coordinator + 24/7 on-call RN — hospice CoP under 42 CFR 418 requires full IDT with specific role coverage; RN case manager 1:12-1:15 ratio; (4) Quality + HQRP + HCI Hospice Care Index — CAHPS family satisfaction + HIS Hospice Item Set + 10 HCI indicators publicly reported on Care Compare; 2024+ HCI underperformance triggers up to 2% Medicare payment reduction; (5) CON approval (in 17 CON states) + accreditation (CHAP/ACHC/TJC) + state DOH license + CMS-855A enrollment + initial certification survey — full licensing stack typical 12-24 months de novo.

🗺️ Table of Contents

Part 1 — Foundations

• [Market size & hospice vs adjacent end-of-life formats](#market-size--hospice-vs-adjacent-end-of-life-formats)
• [CON + state DOH + CMS-855A + CHAP/ACHC/TJC accreditation + CoP licensing stack](#con--state-doh--cms-855a--chapachctjc-accreditation--cop-licensing-stack)
• [Business structure, ownership models & insurance](#business-structure-ownership-models--insurance)

Part 2 — Build-Out & Capital

• [Startup economics & optional GIP inpatient unit](#startup-economics--optional-gip-inpatient-unit)
• [Clinical + EMR + pharmacy + DME + billing software stack](#clinical--emr--pharmacy--dme--billing-software-stack)
• [IDT staffing model & the RN labor crisis](#idt-staffing-model--the-rn-labor-crisis)

Part 3 — Operations

• [Referral pipeline — hospital, SNF/AL, oncology, palliative](#referral-pipeline--hospital-snfal-oncology-palliative)
• [Medicare Hospice Benefit, 4 levels of care & the Cap](#medicare-hospice-benefit-4-levels-of-care--the-cap)
• [Medicare audits, qui tam DOJ, PEPPER & HCI risk](#medicare-audits-qui-tam-doj-pepper--hci-risk)
• [HQRP quality measures — HIS, CAHPS & 2024 HCI](#hqrp-quality-measures--his-cahps--2024-hci)

Part 4 — Growth & Exit

• [Marketing, community education & referral cultivation](#marketing-community-education--referral-cultivation)
• [Scale milestones from 1 office to multi-state platform](#scale-milestones-from-1-office-to-multi-state-platform)
• [PE/strategic consolidation & exit math](#pestrategic-consolidation--exit-math)
• [Counter-case & risks](#counter-case--risks)

---

📐 PART 1 — FOUNDATIONS

Market size & hospice vs adjacent end-of-life formats

A hospice care agency in 2027 is a Medicare-certified interdisciplinary-team (IDT) end-of-life care provider delivering care in patient's home (~95% of hospice days), nursing facility / SNF (~30% of patients have SNF as primary residence), assisted living (~15%), inpatient hospice unit IPU (~1-2% of days at GIP per-diem), and acute hospital (~0.5% of days at GIP) to patients certified terminal with prognosis of six months or less if disease runs its normal course. The US universe spans approximately ~5,800 Medicare-certified hospices serving ~1.7M Medicare beneficiaries annually per CMS Hospice Provider Data + MedPAC + NHPCO (National Hospice and Palliative Care Organization). Industry penetration: ~51% of US Medicare decedents elect hospice in 2024 (up from ~22% in 2000), with state-by-state variation 35-65% (Sun Belt FL/AZ/UT/AR historically high, Northeast NY/MA/NJ historically low). Average daily census (ADC) the dominant operating metric: small hospice <50 ADC, mid <200 ADC, large 200-1,000 ADC, mega 1,000+ ADC (VITAS Healthcare ~50,000 ADC, Amedisys hospice ~14,000 ADC, Compassus ~14,000 ADC, AccentCare hospice ~13,000 ADC, Enhabit ~10,000 ADC).

Hospice must be clinically distinguished from adjacent end-of-life / post-acute formats: (1) Palliative care (q9620 adjacent) — symptom + pain management for serious illness NOT necessarily terminal; can be concurrent with curative treatment (chemo, dialysis, surgery); billed under Medicare Part B physician + facility fees rather than per-diem; delivered in hospital, clinic, home, or hospice; growing rapidly as upstream "bridge to hospice" service. (2) Home Health Agency (HHA — Medicare-certified) — skilled home care for non-terminal patients (post-acute recovery, chronic disease management, wound care, IV therapy); intermittent visit-based reimbursement under PDGM (Patient-Driven Groupings Model since 2020) vs hospice per-diem; certification requires homebound status + skilled need; q9630 adjacent. (3) Non-Medical Home Health Agency (NMHHA / private duty) — non-skilled in-home senior care (personal care, companionship, ADL assistance); not Medicare-covered; private pay + Medicaid waiver + LTC insurance. (4) Skilled Nursing Facility (SNF — q9655) — residential 24/7 RN-supervised; completely different model. (5) Inpatient hospice unit (IPU) — Medicare-certified hospice inpatient bed (either freestanding IPU or hospital-contracted GIP bed) for acute symptom management at GIP per-diem ~$1,180/day; typically 6-30 beds; large hospices operate IPUs as care destination. (6) Acute care hospital + hospitalist palliative consult — non-hospice end-of-life care delivered in hospital. (7) PACE (Program of All-Inclusive Care for the Elderly) — Medicare/Medicaid integrated for nursing-home-eligible at home. (8) Inpatient palliative care unit — specialty hospital unit for serious illness symptom management; not Medicare hospice. (9) Adult day care + AL + MC + IL — non-clinical senior care formats. (10) Bereavement counseling — Medicare hospice CoP requires 13 months of bereavement support to family after patient death; freestanding bereavement counseling is separate service line.

The hospice revenue model rests on Medicare per-diem payment regardless of services delivered that day, with four levels: (1) Routine Home Care (RHC) ~$215/day (FY2025 base rate $223.43/day for first 60 days then $176.21/day day 61+; ~98% of hospice days; care delivered in patient's home/SNF/AL/wherever patient lives); (2) Continuous Home Care (CHC) ~$1,710/day (FY2025 $1,710.39/day full 24-hour day, prorated hourly; for acute crisis at home requiring 8+ hours skilled care/24 hours; rare ~0.2% of days); (3) Inpatient Respite Care (IRC) ~$510/day (FY2025 $507.71/day; up to 5 days at a time in Medicare-certified facility to relieve family caregiver; ~0.3% of days); (4) General Inpatient Care (GIP) ~$1,180/day (FY2025 $1,184.50/day; for acute symptom management in inpatient hospice unit / hospital GIP bed / SNF GIP contracted bed; ~1.5% of days). The Medicare Hospice Cap (~$35K per patient per year aggregate cap on Medicare hospice payment) — FY2025 cap $34,465.34/patient — is the key constraint preventing long-stay/dementia-heavy operators from over-billing; hospices exceeding cap must repay overage to CMS. Typical mature 100-ADC hospice generates $8M-$12M annual revenue at 12-22% EBITDA margin ($960K-$2.6M EBITDA) — healthier than SNF/HHA because per-diem reimbursement provides stable revenue regardless of daily intensity.

Dominant US hospice operator names useful as benchmarks: VITAS Healthcare (Chemed Corporation NYSE: CHE — largest US for-profit hospice ~50,000 ADC across 14 states, market cap ~$8.5B) — owned by Chemed which also owns Roto-Rooter, Amedisys Hospice (NASDAQ: AMED — Optum/UnitedHealth acquisition announced 2023 deal pending FTC review through 2024-2025, ~14,000 hospice ADC, also operates home health), Enhabit (NYSE: EHAB — spun off from Encompass Health 2022, hospice + home health ~10,000 hospice ADC), Encompass Health (NYSE: EHC — IRF + post-acute, hospice spun out as Enhabit), Compassus (Audax Group + TowerBrook PE backed, ~14,000 hospice ADC across 30 states with Ascension Health JV), Bristol Hospice (Webster Equity Partners PE-backed, multi-state), Pennant Group (NASDAQ: PNTG — Ensign Group hospice spinoff, ~5,000 ADC), AccentCare (Advent International PE-backed, hospice + home health, ~13,000 hospice ADC), HouseWorks (Audax-backed, home care + hospice), Aveanna Healthcare (NASDAQ: AVAH — home health + hospice + private duty), LHC Group (UnitedHealth/Optum acquired 2023, hospice + home health), Humana CenterWell Hospice (formerly Curo Health Services — Humana acquired 2018 then partial divestiture to Welsh Carson + Clayton Dubilier 2021), Heart 'n Home Hospice & Palliative Care (Idaho-based regional, ~600 ADC), Hospice of the Valley (Phoenix, largest US nonprofit hospice ~3,500 ADC), Seasons Hospice & Palliative Care (acquired by AccentCare 2020), Suncrest Hospice, Traditions Health, Brighton Hospice, Three Oaks Hospice, By the Bay Health (Bay Area nonprofit), Hospice of Michigan, Care Dimensions (Massachusetts nonprofit), Hospice of the Western Reserve (Cleveland nonprofit), MJHS Hospice (NYC), Calvary Hospital (Bronx, only specialty hospital for hospice), Capital Caring Health (DC area nonprofit). Industry structure: ~60% nonprofit historically, but for-profit market share has grown from ~30% (2000) to ~70% (2024) with PE consolidation driving for-profit growth and nonprofit margin pressure.

CON + state DOH + CMS-855A + CHAP/ACHC/TJC accreditation + CoP licensing stack

Hospice faces a multi-layered federal CMS + state DOH + accreditation regulatory stack — less intensive than SNF (no 42 CFR 483 + no NFPA 101/99 + no Five-Star rating) but with significant complexity especially in 17 CON states that still gate hospice entry. The dominant stack a new operator must navigate:

(1) Certificate of Need (CON) — 17 states still operate CON for hospice including NY, NC, GA, TN, KY, WV, VA, MS, AL, SC, MD, DC, CT, RI, ME, VT, NH, HI (varies by year as states periodically reform/repeal CON). CON application $15K-$125K legal + consulting + application fees, 6-18 month review process, public hearings, competing applications, success rates 25-55% depending on state and market need analysis. New entrants in CON states often find acquisition of existing licensed hospice (CHOW) more practical than de novo CON application. (2) State Department of Health (DOH) hospice license — every state requires state DOH or equivalent hospice license; annual recertification + complaint surveys + new-facility inspections + change-of-ownership review; state DOH licensing fees $2K-$12K initial + $500-$3K annual. (3) CMS Form 855A Medicare Provider Enrollment — institutional provider enrollment for Medicare hospice; initial certification survey by state DOH on behalf of CMS validates compliance with 42 CFR 418 Conditions of Participation before Medicare provider number issued; first patient admission required within 6 months of CMS approval; initial Medicare certification survey at 6-month mark validating CoP compliance; typical 12-24 month process de novo from application to active Medicare hospice provider number including state license + accreditation + CMS-855A + initial certification survey. CHOW (change of ownership) of existing hospice triggers new CMS provider number application + re-survey — typical 60-180 day process with provisional billing during pendency. (4) Accreditation by CHAP / ACHC / TJC — CMS deems accreditation by one of three approved accreditors equivalent to CMS certification survey: CHAP (Community Health Accreditation Partner) dominant home health + hospice accreditor, ACHC (Accreditation Commission for Health Care) second-largest, The Joint Commission (TJC) legacy hospital-focused accreditor with hospice program. Accreditation $8K-$35K initial application + $5K-$15K annual with on-site survey every 3 years + interim self-assessment. (5) CMS Conditions of Participation 42 CFR 418 — federal regulatory backbone covering §418.52 Patient rights, §418.54 Initial and comprehensive assessment, §418.56 Interdisciplinary group (IDT) + care planning + coordination of services, §418.58 Quality assessment and performance improvement (QAPI), §418.60 Infection control, §418.62 Licensed professional services, §418.64 Core services (physician + nursing + medical social services + counseling chaplain/bereavement/dietary), §418.66 Nursing services waiver, §418.68 Furnishing of non-core services, §418.70 Furnishing of room and board, §418.72 Furnishing of physical therapy / OT / SLP, §418.74 Waiver of requirement, §418.76 Hospice aide and homemaker services, §418.78 Volunteers (≥5% of total patient care hours requirement), §418.100 Organization and administration of services, §418.102 Medical director, §418.104 Clinical records, §418.106 Drugs and biologicals + DME, §418.108 Short-term inpatient care, §418.110 Hospices that provide inpatient care directly, §418.112 Hospices that provide hospice care to residents of SNF/NF/ICF-IID, §418.113 Emergency preparedness, §418.114 Personnel qualifications, §418.116 Compliance with federal, state, and local laws. Annual standard survey by state DOH or accreditor validates compliance. (6) CMS Hospice Quality Reporting Program (HQRP) — mandatory quality reporting tied to Medicare payment under Section 3004 of Affordable Care Act; failure to report = 4% Medicare payment reduction. (7) HIS (Hospice Item Set) — patient-level data collection at admission + discharge covering 8 admission measures + 1 discharge measure (NQF-endorsed) measuring care processes (pain assessment, dyspnea screening + treatment, opioid bowel regimen, treatment preferences, beliefs/values). (8) CAHPS Hospice Survey — bereaved-family satisfaction survey administered to family caregivers 2-3 months after patient death; publicly reported on Care Compare; covers communication, getting hospice care training, getting timely help, treating with respect, emotional/spiritual support, help for pain/symptoms, side effects of opioid medications, rating of care, willingness to recommend. (9) HCI (Hospice Care Index) — 2022+ composite quality index with 10 indicators measuring service intensity + access + nursing/aide visit patterns + GIP utilization + skilled nursing minutes + visits in last 3/7 days of life + live discharges + early/late live discharges + bereavement contact; publicly reported on Care Compare; HCI underperformance + future VBP linking under 2024+ HCI triggers up to 2% Medicare payment reduction. (10) Medicare Cap (~$35K/patient/year) — aggregate Medicare hospice payment cap per patient per year; FY2025 $34,465.34/patient; hospices exceeding cap must repay overage to CMS via annual cap reconciliation. (11) Volunteer hours requirement — CoP §418.78 requires volunteer hours ≥5% of total patient care hours; tracked + reported; failure = survey deficiency. (12) Sequential billing + Notice of Election (NOE) within 5 days + Notice of Termination/Revocation (NOTR) within 5 days — required Medicare claim discipline; missed NOE/NOTR = payment denial. (13) Physician certification + recertification — initial certification requires two physicians (hospice medical director + attending physician); recertification at end of each benefit period (90 days first + 90 days second + unlimited 60-day periods thereafter) requires face-to-face encounter by hospice physician or NP within 30 days of recertification; missed F2F = payment denial. (14) HIPAA — full HIPAA compliance + BAA business associate agreements with vendors. (15) DEA registration — hospice typically holds DEA registration for medical director + NPs prescribing controlled substances (opioids dominant for pain management); DEA-X waiver no longer required (eliminated 2022).

(16) Hospice Medical Director (HMD) — Board-certified hospice + palliative medicine (HPM) physician preferred but not required; per CoP responsible for medical component of patient care including certification + recertification + IDT participation + plan of care oversight; typically 0.2-1.0 FTE contracted physician at $185K-$385K annualized depending on ADC scale + responsibilities. (17) NP (Nurse Practitioner) on staff for face-to-face recertification — Medicare regulation since 2011 requires face-to-face encounter at recertification beyond 180 days conducted by hospice physician or hospice NP; many hospices employ NPs ($115K-$155K) for F2F efficiency. (18) State-specific staffing + IDT requirements — many states layer additional requirements on top of federal CoP (e.g. RN-on-call 24/7 in some states beyond CoP §418.64 baseline). (19) Background checks + abuse registry — every direct care employee requires criminal background check + state nurse aide abuse registry; CNA certification for hospice aides (state-specific training + competency).

The disciplined new operator: hires Hospice Medical Director (HMD), Administrator (executive director / hospice administrator), Director of Patient Care Services (RN, hospice CoP-required clinical leadership) before opening, retains healthcare regulatory counsel specialized in hospice in target state, engages CHAP/ACHC/TJC accreditation consultant for initial accreditation survey preparation, builds compliance officer + QAPI program + Medicare cap monitoring + PEPPER report monitoring + HQRP/HIS/CAHPS/HCI reporting capability before opening, and treats audit avoidance + length-of-stay discipline + IDT compliance + accreditation maintenance as highest operating priorities.

Business structure, ownership models & insurance

The dominant hospice ownership structure in 2026 is for-profit LLC or corporation owned by founder/PE/strategic — for-profit market share has grown from ~30% (2000) to ~70% (2024) driven by PE consolidation. Alternative structures: (a) Nonprofit 501(c)(3) hospice — historically dominant model especially community-based hospices (Hospice of the Valley, Care Dimensions, Hospice of Michigan, Calvary Hospital, MJHS Hospice, By the Bay Health, Capital Caring Health) with 501(c)(3) tax exemption + access to charitable contributions + community board + mission-driven culture; (b) Hospital-affiliated hospice — health system operating hospice as service line (Cleveland Clinic Hospice, Penn Medicine Hospice, UCSF Care at Home); (c) PE-backed for-profit platform (VITAS / Chemed, Amedisys, Compassus, Bristol Hospice, Pennant Group, AccentCare, HouseWorks); (d) Strategic-owned (insurance + senior services integration) — Humana CenterWell, Optum/UnitedHealth (LHC, Amedisys); (e) Single-founder owner-operator — common entry path for nurse-founder / physician-founder starting de novo hospice. Entity structure: standard pattern is single LLC (Delaware or state-specific) holds Medicare provider number + employs staff + contracts with physicians + holds DEA registration + holds vendor agreements. Working capital requirement notably lower than SNF — hospice cash flow cycle 30-60 days (Medicare RAP Request for Anticipated Payment historically provided early cash but RAP eliminated 2022; Notice of Election + initial claim + remittance typical 30-60 days); typical de novo hospice needs $185K-$485K operating capital to absorb pre-stabilization burn during 6-18 month census ramp.

Insurance stack (lighter than SNF because terminal patients = limited damages framework + home-care delivery = lower premises liability + interdisciplinary documentation discipline): (1) Professional Liability (Med Mal) + General Liability — combined PL + GL with limits typically $1M/$3M per claim/aggregate minimum, $2M/$5M-$3M/$10M preferred, $5M-$15M for multi-state operators; premium $25K-$185K annually per 100-ADC hospice (varies by state — California, Florida, Texas, New York are higher-cost plaintiff venues); key carriers include CNA HealthPro, MedPro Group (Berkshire Hathaway), ProAssurance (NYSE: PRA), The Doctors Company, Coverys, Beazley, AXA XL, AIG, Hiscox, Berkshire Hathaway Specialty, Markel, Distinguished Programs, Arthur J Gallagher, Marsh McLennan, USI, HUB International, Lockton, Newfront. (2) Workers Compensation — hospices typically classified under NCCI 8826 Home Health Care Skilled and Unskilled (the home health + hospice class code); premium $2.50-$6.50 per $100 of payroll (moderate-to-high WC rate driven by RN/CNA driving + patient handling + needle-stick); typical 100-ADC hospice with $4M-$6M payroll = $100K-$390K annual WC premium. (3) Auto / Hired & Non-Owned Auto — hospice clinicians drive to patient homes (most clinical visits are home visits); typically non-owned auto policy with $1M-$2M limit covering employee-owned vehicles used for hospice work; $8K-$45K annually for 100-ADC hospice with 20-40 clinicians driving; some hospices provide company vehicles (more common for medical director / administrator). (4) Property + Business Interruption — office space + IPU (if equipped) full replacement value with BI rider; $5K-$45K annually office-only; $25K-$125K annually if IPU operated. (5) Cyber Liability at $2M-$5M — HIPAA breach + ransomware (hospices major ransomware targets given patient PHI + family bereavement data) — $8K-$45K annually. (6) EPLI Employment Practices Liability at $1M-$3M — RN turnover + clinician HR complaints = moderate EPLI exposure — $8K-$25K annually. (7) Umbrella Liability at $5M-$25M — multi-site hospices routinely carry $10M-$50M umbrella — $15K-$125K annually. (8) Sexual Abuse + Molestation sub-limit at $500K-$3M — vulnerable terminal patient population + family bereavement contact — $3K-$25K annually. (9) Crime / Employee Dishonesty at $250K-$1M — protects against employee theft from patients (rare but real exposure in home visits) — $2K-$8K annually. (10) Directors & Officers (D&O) at $1M-$5M — $8K-$35K annually. (11) Pollution Liability — covers medical waste (sharps + biohazard) — $2K-$15K annually. (12) Bond + Surety — required by some states for Medicare/Medicaid provider — $1K-$5K annually. Total Year 1 insurance load for a 100-ADC hospice: $150K-$650K (premium urban high-litigation states $250K-$950K; multi-state platforms with SIR $500K-$3M aggregated). Contract discipline: every admission includes (a) hospice election form (Medicare CMS-1450 election + revocation rights), (b) plan of care + IDT-developed care goals, (c) advance directive documentation (POLST/MOLST/Living Will/DNR/Healthcare POA), (d) HIPAA authorization, (e) bereavement consent + contact preferences, (f) financial responsibility (Medicare/Medicaid + any non-covered services), (g) DNR/AND code status confirmation, (h) photograph release.

---

🧱 PART 2 — BUILD-OUT & CAPITAL

Startup economics & optional GIP inpatient unit

Hospice startup capital is dramatically lower than SNF/AL/MC because care is delivered in patient's home / SNF / AL / wherever patient lives (~95% of hospice days at Routine Home Care) rather than purpose-built facility. Five paths: (1) De novo Medicare-certified hospice in non-CON state — typical $185K-$485K startup capital covering office lease ($24K-$85K annual), CMS-855A + state DOH license ($5K-$25K), accreditation CHAP/ACHC/TJC ($15K-$45K initial), EMR ($25K-$85K initial + $1K-$3K/mo subscription), startup IDT staff payroll runway 6-12 months ($85K-$285K), insurance Year 1 ($25K-$95K), legal + consulting ($25K-$85K), branding + website + initial marketing ($15K-$45K), miscellaneous (laptops + phones + medical bags + initial supplies $25K-$65K). 12-24 months from application to active Medicare provider number + first patient admission within 6 months of CMS approval + initial certification survey at 6-month mark + census ramp 0-50 ADC over 12-18 months. (2) De novo in CON state — typical $485K-$1.5M startup capital including CON application $15K-$125K + CON consulting $50K-$185K + 12-18 month CON review with public hearings + competing applications + 25-55% success rate; CON-state new entry often impractical without bed/license relocation. (3) Acquire existing operating hospice (CHOW) — typical $1.5M-$8M acquisition for 50-150 ADC hospice with active Medicare provider number + accreditation + referral relationships; multiples typically 0.8-1.5x annual revenue OR 6-10x EBITDA (depending on payer mix + ADC + survey + audit history + state); CHOW 60-180 days with provisional billing risk during pendency; easiest path in CON states or when speed to operating hospice required. (4) Acquire + build (regional rollup) — PE-backed strategy acquiring 2-5 existing hospices in geographic concentration then organic growth + adjacent acquisition. (5) Hospital/health-system joint venture or hospice subsidiary — health system funds + operates hospice as service line; lower capital risk but slower growth + governance complexity.

Optional GIP (General Inpatient) unit — Medicare-certified inpatient hospice bed for acute symptom management at GIP per-diem ~$1,180/day. Two GIP models: (a) Freestanding IPU (Inpatient Patient Unit) — purpose-built or converted facility, typically 6-30 beds, capital $3M-$15M for facility + equipment + working capital; only large hospices (>500 ADC) typically operate freestanding IPU; (b) Contracted GIP bed — hospice contracts with hospital, SNF, or freestanding IPU for GIP bed access at per-diem rate (typically hospital partner takes $400-$650/day of the $1,180 GIP per-diem leaving hospice $500-$750/day margin after hospice IDT services delivered in inpatient setting); most hospices use contracted GIP rather than freestanding IPU. Disciplined GIP utilization typically 1-3% of total patient days — over-utilization triggers PEPPER report flag + UPIC audit + payment recoupment (DOJ has prosecuted multiple hospices for inappropriate GIP billing).

Office build-out — typical 100-ADC hospice office 2,500-5,000 sqft in commercial office building with administrator office + medical director office + IDT meeting room (large enough for full IDT including all RN case managers + MSWs + chaplain + HHA coordinator + volunteer coordinator + medical director) + clinical staff workstations + medication storage (DEA-compliant Schedule II controlled substance storage for opioid stock if hospice maintains comfort kits) + records storage (HIPAA-compliant) + reception + break room; rent $24K-$85K annual depending on metro; tenant improvements $35K-$185K. Sub-market selection criteria: (1) Medicare beneficiary density — 65+ population in service area (typically 30-45 minute drive from office for clinical visit efficiency); minimum 25K-65K Medicare beneficiaries in catchment for 100-ADC viability; (2) Hospital + SNF + AL discharge volume — 3-8 acute care hospitals + 15-30 SNFs + 25-60 AL/MC facilities in service area producing referral pipeline; (3) Existing hospice competition — assess via CMS Hospice Compare + Hospice Provider Data + state DOH hospice list to understand competing supply, market penetration, dominant local operators; mature markets (FL, AZ, TX, CA) have 8-25+ hospices competing for referrals; under-served rural markets may have 1-3 hospices; (4) State Medicaid hospice rate — most states mirror Medicare per-diem (RHC ~$215/day) but some pay slightly less; state hospice carve-out vs Medicaid managed care affects payment timing; (5) CON status — CON state (NY/NC/GA/TN/KY/WV/VA/MS/AL/SC/MD/DC/CT/RI/ME/VT/NH/HI) substantially harder de novo entry; (6) Labor market — RN + LPN + HHA + MSW + chaplain availability + wage benchmarks; tight labor markets squeeze margins. Working capital — typical 100-ADC hospice needs $185K-$485K working capital at stabilization for 30-60 day Medicare A/R cycle + payroll + vendor payments + cap reserve.

Clinical + EMR + pharmacy + DME + billing software stack

Hospice clinical/operating tech stack must support electronic medical record (EMR) integrated with IDT + plan of care + MDS-equivalent assessments, Medicare claims processing including NOE/NOTR + per-diem billing + cap monitoring, pharmacy integration for hospice formulary + comfort kit + IV management, DME (durable medical equipment) coordination for hospital bed + oxygen + commode + walker, scheduling + visit management for IDT visits, CAHPS + HIS + HCI quality reporting, family portal + bereavement contact, volunteer management — substantially less complex than SNF but specialized for hospice workflow. The dominant hospice platforms in 2025-2026:

(1) Homecare Homebase (Hearst Health-owned) — dominant home health + hospice EMR/platform with ~30%+ hospice market share including VITAS Healthcare, Amedisys, Compassus, Pennant Group, HouseWorks; full clinical EMR + IDT + plan of care + scheduling + claims; pricing $185-$385 per ADC per month all-in; hchb.com. (2) MatrixCare Hospice (ResMed-owned) — major hospice EMR (also dominant in SNF); pricing $145-$285 per ADC per month; matrixcare.com. (3) Hospice Tools (Hospice Soft) — hospice-specific EMR for small-to-mid hospices; hospicetools.com. (4) MUMMS Healthcare Solutions (Mediware/WellSky-owned) — hospice + home health EMR; wellsky.com. (5) KanTime Hospice — hospice EMR for mid-market; kantime.com. (6) Forcura — workflow + intake + clinical document management for hospice + home health; forcura.com. (7) Brightree Hospice (ResMed-owned) — hospice EMR + intake; brightree.com. (8) NetSmart — behavioral health + senior care + hospice clinical platform; netsmarttech.com. (9) PointClickCare Home and Community Care — PointClickCare's hospice/home care module (PointClickCare dominant in SNF); pointclickcare.com. (10) HEALTHCAREfirst — hospice + home health EMR; healthcarefirst.com. (11) Axxess Hospice — hospice EMR for mid-market; axxess.com. (12) Suncoast Solutions — hospice-specific clinical + financial; suncoastsolutions.com. (13) DeVero Hospice (HHAeXchange-owned) — hospice EMR; devero.com.

Hospice formulary pharmacy — closed-door pharmacy serving hospice patients with 24/7 dispensing + e-prescribing + comfort kit (initial admission opioid + anti-anxiety + anti-nausea + secretion management kit dispensed to home within 4-6 hours) + IV admixture + DEA-compliant Schedule II controlled substance handling + waste destruction. Dominant hospice pharmacies: Enclara Pharmacia (Humana-owned, largest hospice pharmacy nationally serving 35%+ of US hospice ADC), Optum Hospice Pharmacy Services (UnitedHealth-owned, second-largest), HospiScript (Catamaran/OptumRx-owned), Outcome Resources, BetterCare Hospice Pharmacy, ProCare HospiceCare, MedKey, regional hospice pharmacies. Hospice pharmacy typically subcontracted at per-diem $8-$18/patient/day covering all medications (pharmacy bears medication cost risk in capitated arrangement).

DME (Durable Medical Equipment) — hospital bed + wheelchair + commode + walker + oxygen + suction + IV pole + nebulizer delivered to patient home within 4-24 hours of admission; subcontracted to hospice DME vendor at per-diem $5-$15/patient/day or per-event fee. Dominant hospice DME vendors: Apria Healthcare (Owens & Minor-owned, largest hospice DME provider), Rotech Healthcare, Lincare (Linde-owned), AdaptHealth (NASDAQ: AHCO), Quipt Home Medical, regional DME. Oxygen typically separate at $4-$8/patient-day in oxygen subset.

Lab + diagnostics — limited hospice need (hospice generally minimizes labs/diagnostics consistent with palliative goals) but maintained for symptom-management decisions; Quest Diagnostics, LabCorp, regional labs for basic chemistry/CBC when clinically indicated.

Hospice volunteer management — CoP §418.78 requires volunteer hours ≥5% of total patient care hours tracked + reported; volunteer recruitment + screening + training + assignment + scheduling + tracking via volunteer coordinator FTE plus volunteer management software (often built into Homecare Homebase / MatrixCare / Hospice Tools volunteer module).

Bereavement program — CoP requires 13 months of bereavement support to family post-death; bereavement coordinator + chaplain + MSW + volunteers + bereavement groups + memorial services + anniversary contacts; tracked + reported in HCI bereavement indicator.

Billing + revenue cycle management — Medicare hospice claims processing including NOE within 5 days + sequential claims + cap monitoring + ADR Additional Documentation Request response + Medicare appeal: Homecare Homebase RCM, MatrixCare RCM, McKesson, Optum Insight, Change Healthcare (UnitedHealth), Waystar, AthenaCollector, Net Health, RCM Health Care Services, Cantata Health, Allevia, Healthpac, regional hospice RCM specialists. Cap monitoring — critical Medicare hospice compliance function; specialty tools (Optima Cap Reporter, MatrixCare Cap Module, Homecare Homebase Cap, Hospice Cap Group consulting) help operators monitor cap utilization in real-time and adjust admission patterns to avoid cap overage.

Accounting: Sage Intacct, NetSuite, MS Dynamics 365 for multi-state platforms; QuickBooks Online + ADP/Paychex payroll for single-site. HR/payroll: ADP, Paychex, Paylocity, UKG (Kronos), Smartlinx. Scheduling: many hospices use EMR-integrated scheduling (Homecare Homebase, MatrixCare) for IDT visit management; some use OnShift, Smartlinx, ABILITY SmartForce. CRM / referral tracking + intake: Forcura, Trella Health, Playmaker Health (Trella-owned), MyHomecareBiz, MEDarchon, MEDFORCE, Salesforce Health Cloud, HubSpot, custom CRM — critical for tracking 5-15 referral sources + intake conversion + referral attribution. HQRP reporting: HIS + CAHPS + HCI automated via EMR with quarterly + annual CMS submission.

Total Year 1 tech stack cost for 100-ADC hospice: $185K-$485K annually all-in (EMR + pharmacy passthrough + DME passthrough + billing/RCM + scheduling + CRM + accounting + payroll + HQRP). Pharmacy + DME passthrough fees (per-diem $13-$33/patient-day = $475K-$1.2M annually for 100 ADC) are typically captured in cost of care rather than tech stack.

IDT staffing model & the RN labor crisis

Staffing is 40-55% of hospice P&L (lower than SNF because lower labor intensity per patient day at RHC vs SNF 24/7 RN supervision) but still dominant pressure point with RN labor crisis (35-55% hospice RN turnover, $80-$120K hospice RN wages, contract agency RN $85-$135/hour). Hospice CoP under 42 CFR 418 mandates Interdisciplinary Team (IDT) with specific role coverage. The dominant 100-ADC hospice IDT staffing model:

For 100-ADC hospice, total IDT + leadership + BD + business office staff = ~35-55 FTE + contract physician (much leaner than SNF 95-185 FTE because hospice care delivered in patient homes vs SNF 24/7 residential care). 24/7 on-call coverage required per CoP — typically rotated among RN case managers + triage RNs + on-call RNs with on-call differential pay ($1.5-$3.5/hour or $200-$500/weekend). Contract agency reality — hospice RN/NP/HHA contract agency at $85-$135/hour vs $80-$120K core wage = 2.5-3x premium; agency use varies dramatically by market (urban tight markets 8-18% of nursing labor, mid-market 3-8%, rural 1-5%). Disciplined hospice operators focus on RN pipeline + retention (sign-on bonuses $5K-$15K, retention bonuses $2K-$10K, predictable visit-based scheduling, hospice-experience premium $5K-$15K above general RN, career ladder to hospice NP + DPCS + HMD relationship), CHPN/CHPNA certification investment, RN-on-call differential, leadership presence + IDT culture, productivity benchmarks (RN case manager 4-6 visits/day, hospice aide 6-8 visits/day, MSW 2-3 visits/day with phone support), agency reduction toward <5%, turnover toward 25-35% (still high but better than 55%+). CHPN (Certified Hospice and Palliative Nurse) + CHPNA (Certified Hospice and Palliative Nursing Assistant) specialty certifications are quality + retention markers favored by sophisticated operators.

---

⚙️ PART 3 — OPERATIONS

Referral pipeline — hospital, SNF/AL, oncology, palliative

Hospice referral pipeline is the dominant operational reality — 60-75% of admissions flow through 5-15 key referral sources with community liaisons / hospice liaison nurses (hospice-employed BD reps embedded with referral sources) as primary BD function. Losing 1-2 major referral sources can collapse census within 30-60 days. The referral channels for hospice admissions:

(1) Hospital discharge planners + case managers + palliative care teams (PRIMARY — 35-50% of admits) — every acute care hospital has discharge planning department + palliative care consultation team; hospice liaisons build relationships with discharge planners + case managers + attending physicians + hospitalists + palliative care specialists. Daily morning rounds presence + same-day response + accept difficult admits + 24/7 admission capability (including evenings/weekends/holidays) + maintain bed availability + clinical capability + responsive communication are the operational disciplines that win referral share. Palliative care to hospice transition is increasingly the dominant referral pathway — palliative care teams identify patients with terminal trajectory + facilitate goals-of-care conversation + transition to hospice.

(2) SNF + AL + memory care discharge / on-site (20-30% of admits) — many hospice patients reside in SNF (~30% of hospice patients have SNF as primary residence) + AL/MC (~15%); hospice provides on-site IDT services at SNF/AL/MC site; SNF/AL/MC referrals come from facility administrators + DON + social workers; hospice liaisons cultivate relationships with 15-30 SNFs + 25-60 AL/MC facilities in service area. Hospice generally has preferred-hospice arrangements with SNF/AL chains (e.g. Brookdale, Holiday by Atria, Sunrise Senior Living, Atria Senior Living, Capital Senior Living) and works for inclusion in chain preferred-provider lists.

(3) Oncology + cancer center referrals (10-20% of admits) — oncologists at cancer centers (academic NCI-designated + community oncology) refer cancer patients (still ~30% of hospice admissions) when curative treatment exhausted; cultivate relationships with oncology nurses + tumor board + palliative oncology specialists.

(4) Cardiology + nephrology + pulmonology + neurology referrals (5-10% of admits) — specialty physicians refer patients with end-stage organ failure (CHF, ESRD/dialysis discontinuation, COPD/CF, ALS/Parkinson's/dementia); typically smaller volume per specialty office but high-quality referrals.

(5) Geriatric medicine + primary care + community physicians (5-10% of admits) — PCPs + geriatricians + house-call physicians refer chronic disease patients with terminal trajectory; high-quality referrals but require ongoing physician education on hospice eligibility + benefits.

(6) Home Health Agency (HHA) step-down referrals (3-7% of admits) — patients on Medicare home health who decline / no longer benefit from skilled rehabilitation referred to hospice; HHA-hospice transition relationships valuable.

(7) Adult day care + senior services + community organizations (1-3% of admits) — ADC + senior centers + Area Agency on Aging + faith-based community + Meals on Wheels generate occasional referrals.

(8) Family / community direct admits (2-5% of admits) — direct family inquiry via website + community education + word-of-mouth + bereavement family referrals (families who used hospice for prior loved one).

(9) Hospital system / health system contracted hospice — some health systems contract with single hospice as preferred provider for system patients; competitive contract typically renewed annually.

(10) Insurance case managers + Medicare Advantage — MA plan case managers + commercial insurance case managers refer; growing as MA penetration grows (~50% of Medicare lives now MA + VBID hospice carve-in pilot 2021-2024 with mostly carve-out 2025+).

(11) VA + Indian Health Service + Tribal referrals — VA Community Care Network + IHS + tribal health programs refer veterans + Native Americans; specialty referral channel.

(12) Long-term care insurance + private referral — LTC insurance case managers occasionally refer; small volume but high-quality.

(13) Funeral home + bereavement referrals — funeral homes occasionally refer pre-need families; small volume but community connection.

Admission cycle: (a) Referral receipt (referral source sends referral with clinical history, prognosis indicators, recent labs/imaging, attending physician info), (b) Clinical eligibility review by intake RN (assess Medicare hospice eligibility — terminal prognosis ≤6 months if disease runs normal course, specific eligibility criteria per diagnosis — cancer + cardiopulm + dementia FAST 7C + ALS + AIDS + ESRD + adult failure to thrive + other), (c) Insurance verification + Medicare hospice election form preparation, (d) Information visit by intake RN + MSW + chaplain at patient home (or hospital / SNF / AL) — explain hospice services + benefits + revocation rights + plan of care + bereavement support + answer questions + obtain election, (e) Hospice election signed + admission orders + initial IDT plan of care developed within 5 days + Notice of Election (NOE) submitted within 5 days to CMS, (f) Initial home visit by RN case manager + symptom management initiation + comfort kit delivery + DME delivery + chaplain/MSW visits scheduled + hospice aide visits scheduled + volunteer assignment + 24/7 on-call orientation for family. The disciplined hospice runs 24/7 admissions accepting (evenings + weekends + holidays — major competitive advantage), same-day-of-referral response (admit within 24 hours of referral or ASAP), clinical capability to accept complex admits (GIP-required acute symptom management, IV therapy, complex wounds, behavioral, pediatric hospice if equipped, perinatal hospice), and maintained ADC growth toward 100-200+ census.

Medicare Hospice Benefit, 4 levels of care & the Cap

The Medicare Hospice Benefit is the economic + regulatory foundation of the hospice industry — established by the 1982 Tax Equity and Fiscal Responsibility Act (TEFRA) and codified at 42 CFR 418 Conditions of Participation + Medicare Benefit Policy Manual Chapter 9 Hospice. Eligibility requires: (a) patient entitled to Medicare Part A; (b) patient certified by two physicians (hospice medical director + attending physician) to have terminal prognosis of six months or less if disease runs its normal course; (c) patient elects hospice care (signs hospice election form waiving curative treatment for terminal diagnosis — patient retains Medicare Part A/B for unrelated conditions). Benefit periods: (1) First 90-day benefit period + (2) Second 90-day benefit period + (3) Unlimited 60-day benefit periods thereafter; recertification at end of each period requires face-to-face (F2F) encounter by hospice physician or NP within 30 days of recertification + clinical documentation of continued terminal prognosis.

Four Medicare hospice levels of care + per-diem rates (FY2025 base rates per CMS):

(1) Routine Home Care (RHC) — ~$215/day (FY2025 base $223.43/day first 60 days + $176.21/day day 61+, with U-shaped reimbursement to incentivize shorter stays + adequate end-of-life intensity). ~98% of all hospice days. Care delivered in patient's home / SNF / AL / wherever patient lives. RHC per-diem covers all hospice services for that day regardless of intensity — RN case manager visits, MSW visits, chaplain visits, hospice aide visits, NP/MD visits, medications related to terminal diagnosis, DME, supplies, on-call coverage, volunteer services, bereavement preparation. Patient pays $0 for hospice services + $0 for medications + $0 for DME (Medicare hospice benefit covers all hospice-related costs); patient retains Medicare A/B for unrelated conditions. Service Intensity Add-on (SIA) — additional payment for RN + MSW visits in last 7 days of life at hourly rate (FY2025 ~$67/hour up to 4 hours/day) — incentive for adequate end-of-life intensity.

(2) Continuous Home Care (CHC) — ~$1,710/day (FY2025 $1,710.39/day prorated hourly at $71.27/hour). For acute crisis at patient home requiring continuous skilled care (≥8 hours of skilled care within 24 hours predominantly nursing) to manage acute symptom flare or imminent death; alternative to inpatient transfer. Rare ~0.2% of hospice days nationally but disciplined hospices use CHC appropriately for crisis intervention preserving home care + family preferences.

(3) Inpatient Respite Care (IRC) — ~$510/day (FY2025 $507.71/day). Up to 5 days at a time in Medicare-certified facility (hospital, SNF, IPU) to relieve family caregiver. ~0.3% of hospice days. Disciplined hospices offer respite proactively to support family caregivers preventing crisis admission.

(4) General Inpatient Care (GIP) — ~$1,180/day (FY2025 $1,184.50/day). For acute symptom management requiring inpatient level care — uncontrolled pain, intractable nausea/vomiting, dyspnea/respiratory distress, terminal restlessness/agitation, IV medications requiring inpatient setting. Care delivered in Medicare-certified hospice inpatient unit (IPU) or contracted GIP bed in hospital / SNF. ~1.5% of hospice days for disciplined operators; over-utilization triggers PEPPER + UPIC audit + payment recoupment + DOJ qui tam exposure (DOJ has prosecuted multiple hospices for inappropriate GIP billing). Sophisticated hospices balance GIP utilization between under-utilization (under-serving acute symptom needs) and over-utilization (audit flag).

Medicare Hospice Cap (aggregate annual cap per patient) — FY2025 $34,465.34 per patient per year (CMS publishes annually; adjusted by hospital market basket index). Calculated as (total Medicare hospice payments to hospice during cap year) / (total Medicare beneficiaries served during cap year × cap per patient) ≤ 1.0. Hospices exceeding cap must repay overage to CMS via annual cap reconciliation (typically settled 12-18 months after cap year end). Cap is the dominant constraint preventing long-stay/dementia-heavy operators from over-billing — dementia patients (FAST 7C eligibility ambiguous, LOS frequently 12-36 months) can push hospices into cap overage if dementia % too high without offsetting short-stay patients. Disciplined hospices monitor cap utilization in real-time via cap reporting tools (Optima Cap Reporter, MatrixCare Cap, Homecare Homebase Cap) and adjust admission mix to balance long-stay + short-stay patients keeping cap utilization at 85-95%.

Sequential billing + NOE + NOTR discipline — Medicare hospice claims billed monthly per benefit period sequentially with Notice of Election (NOE) submitted within 5 days of admission + Notice of Termination/Revocation (NOTR) submitted within 5 days of discharge/revocation/death. Missed NOE = payment denial for entire benefit period (CMS introduced 5-day NOE timely filing in 2014, with strict enforcement); missed F2F recertification = payment denial for that benefit period. Sophisticated hospices maintain NOE filing discipline at 99%+ on-time as basic operational hygiene.

Medicare Advantage hospice integration — VBID Model + carve-out reality — historically Medicare hospice is carved out of Medicare Advantage (MA plan does not pay hospice; CMS fee-for-service Medicare pays hospice directly even for MA enrollees who elect hospice); CMS piloted VBID (Value-Based Insurance Design) Hospice Component 2021-2024 allowing select MA plans to administer hospice benefit (carve-in); VBID Hospice Component expired December 2024 with most MA plans returning to carve-out for 2025+. Operators should plan for continued carve-out reality with periodic VBID-style reform pilots.

Medicare audits, qui tam DOJ, PEPPER & HCI risk

Medicare audit + DOJ qui tam False Claims Act + PEPPER + HCI scrutiny is the largest single existential risk for hospice operators — DOJ has recovered $3B+ in hospice False Claims Act settlements 2010-2024. Major named cases: (a) AseraCare — $1B settlement initially (largest hospice FCA case ever) ultimately reversed on 11th Circuit appeal 2019 (court ruled mere medical opinion difference insufficient for FCA liability) but legacy + chilling effect lives on; (b) Chemed Corporation / VITAS Healthcare — multiple settlements totaling $75M+ for inappropriate GIP billing + long-stay patients + crisis care over-utilization; (c) Hospice of Cincinnati — $19M settlement; (d) Halifax Hospice — $85M settlement; (e) SouthernCare Inc — $24.7M settlement; (f) Hospice Plus / Curo Health Services — $12.2M settlement (Curo now Humana CenterWell); (g) numerous smaller settlements $2M-$20M range; (h) ongoing qui tam (whistleblower) FCA cases filed by former employees + nurses + physicians under seal with potential 15-30% relator share of settlements driving plaintiff bar interest.

Federal hospice audit + enforcement apparatus:

(1) UPIC (Unified Program Integrity Contractor) — CMS-contracted audit contractor performing post-payment review of Medicare hospice claims flagged by data analytics + complaints + referral; can request medical records via ADR (Additional Documentation Request) and recoupment if claims unsupported. Major UPICs: CGI Federal (Northeast), Performant Recovery (Midwest), SafeGuard Services (Southeast + West), AdvanceMed (West).

(2) ZPIC (Zone Program Integrity Contractor) — predecessor to UPIC, still referenced in legacy contracts; same fraud + abuse investigation function.

(3) TPE (Targeted Probe and Educate) — MAC (Medicare Administrative Contractor)-run program reviewing 20-40 claims per round (up to 3 rounds), providing education between rounds, with MAC referral to UPIC + recoupment if not improved after 3 rounds. Major MACs for hospice: Palmetto GBA (JM), CGS Administrators (JN), National Government Services (J6, JK), Noridian (JE, JF), Novitas Solutions (JL, JH), First Coast Service Options (JN).

(4) RAC (Recovery Audit Contractor) — contingency-fee audit contractor reviewing claims for over-payment; less active in hospice than UPIC but periodic involvement.

(5) OIG (Office of Inspector General — HHS) — federal investigative + audit arm performing Work Plan audits + Compliance Program reviews + Corporate Integrity Agreements (CIA) post-settlement; OIG publishes annual Work Plan identifying hospice audit priorities (length-of-stay, GIP utilization, eligibility documentation, FAST 7C dementia, live discharge patterns).

(6) DOJ (Department of Justice) — federal criminal + civil prosecution arm; DOJ qui tam False Claims Act actions filed under seal by whistleblowers (former employees, nurses, physicians) with potential 15-30% relator share of settlements driving plaintiff bar interest; DOJ has filed dozens of hospice FCA cases recovering $3B+ 2010-2024.

(7) PEPPER (Program for Evaluating Payment Patterns Electronic Report) — TMF Health Quality Institute-prepared comparative analytics report distributed quarterly to every Medicare hospice via CMS PEPPER portal. PEPPER reports each hospice's percentiles vs national/state peers on 8 hospice-specific outlier indicators: (a) Long Length of Stay > 180 days, (b) Long Length of Stay > 365 days, (c) Live Discharge for Reasons Other Than Patient Decision (LD-Cap), (d) Live Discharge from Hospice (LD-General), (e) Hospice in a Nursing Facility (HNFR), (f) Continuous Home Care + General Inpatient Care Use, (g) Single Diagnosis (FAST 7C dementia, debility, adult failure to thrive, etc — non-cancer diagnoses), (h) No General Inpatient Care Or Continuous Home Care Use. Hospices in 80th+ percentile (or in some cases 20th percentile for under-utilization) face elevated audit risk + recommended internal review + potential UPIC referral. PEPPER is the dominant comparative analytics tool driving CMS audit selection.

(8) HCI (Hospice Care Index) — CMS 2022+ composite quality index with 10 indicators publicly reported on Care Compare: (1) Hospice Visits in Last Days of Life (HVLDL), (2) Continuous Home Care or General Inpatient provided, (3) Gaps in Skilled Nursing Visits, (4) Early Live Discharges from Hospice, (5) Late Live Discharges from Hospice, (6) Burdensome Transitions (Type 1), (7) Burdensome Transitions (Type 2), (8) Per-beneficiary Medicare spending, (9) Skilled Nursing Care Minutes per Routine Home Care Day, (10) Skilled Nursing Minutes on Weekends per Routine Home Care Day. 2024+ HCI underperformance triggers up to 2% Medicare payment reduction under Hospice Quality Reporting Program (HQRP) value-based payment linkage.

(9) Length-of-stay (LOS) scrutiny — long-stay (LOS > 180 days, > 365 days) + live-discharge (patient discharged alive from hospice — often interpreted as ineligibility / over-admission) + FAST 7C dementia eligibility are the dominant audit flags. Sophisticated hospices monitor: (a) Long-stay % (target <20% LOS > 180 days, <10% LOS > 365 days), (b) Live discharge % (target <12-18%), (c) FAST 7C dementia % (no hard cap but operators with > 35% FAST 7C dementia face elevated audit attention), (d) Average LOS (target 60-120 days; <30 days suggests late referrals, >150 days suggests possible over-admission), (e) Median LOS (target 14-30 days; reflects right-mix of short-stay cancer + long-stay dementia).

(10) FAST 7C dementia eligibility ambiguity — FAST (Functional Assessment Staging Tool) is the dementia staging instrument; FAST 7C is Medicare hospice eligibility threshold for Alzheimer's / dementia (defined as: progression to FAST 7 + speech limited to ≤6 intelligible words/day + non-ambulatory + dependent in all ADLs + plus secondary conditions). FAST 7C is clinically ambiguous + subject to disagreement among physicians + #1 audit target. Sophisticated hospices document objective FAST 7C criteria + secondary conditions (recurrent UTI, recurrent aspiration pneumonia, weight loss, decubitus ulcer, recurrent ED visits) + clinical judgment by hospice medical director + attending physician to support FAST 7C eligibility.

(11) Compliance program + corporate integrity — sophisticated hospices maintain OIG-compliant compliance program (written policies + training + monitoring + reporting + investigation + enforcement), internal Medicare cap monitoring + PEPPER review + HCI review (quarterly minimum), internal medical record audit + eligibility validation, whistleblower reporting hotline + non-retaliation policy, OIG Exclusion List monthly screening (no excluded individuals can work for Medicare provider), CIA (Corporate Integrity Agreement) compliance if applicable post-settlement.

The audit + qui tam exposure is the dominant financial + reputational risk in hospice — sophisticated operators treat compliance + audit posture as the highest operational priority above growth.

HQRP quality measures — HIS, CAHPS & 2024 HCI

Hospice Quality Reporting Program (HQRP) — mandatory CMS quality reporting program under Section 3004 of Affordable Care Act; failure to report = 4% Medicare payment reduction. Three components:

(1) HIS (Hospice Item Set) — patient-level data collection at admission + discharge covering 8 admission measures + 1 discharge measure: (a) Treatment Preferences (CPR + hospitalization preferences documented), (b) Beliefs/Values Addressed (if applicable), (c) Pain Screening (within 1 day of admission), (d) Pain Assessment (if positive pain screen — within 1 day of positive), (e) Dyspnea Screening (within 1 day of admission), (f) Dyspnea Treatment (if positive screen — within 1 day of positive), (g) Patients Treated with Opioid Bowel Regimen (within 1 day of opioid initiation), (h) Hospice Visits when Death is Imminent — Measure 1 (RN/MD/NP/PA visit within 3 days of death), (i) Hospice Visits when Death is Imminent — Measure 2 (2+ visits by RN/MD/NP/PA/MSW/chaplain in last 7 days of life). HIS data submitted quarterly via HIS-V3 XML upload to CMS QIES ASAP system; HIS measures publicly reported on Care Compare (medicare.gov/care-compare).

(2) CAHPS Hospice Survey — bereaved-family satisfaction survey administered by CMS-approved CAHPS vendor (typically NRC Health, Press Ganey, Strategic Healthcare Programs SHP, Deyta Analytics, HEALTHCAREfirst CAHPS) to family caregivers 2-3 months after patient death. CAHPS measures 8 composite areas: (a) Communication with Family (5 questions), (b) Getting Hospice Care Training (3 questions), (c) Getting Timely Help (2 questions), (d) Treating Patient with Respect (2 questions), (e) Emotional and Spiritual Support (3 questions), (f) Help for Pain and Symptoms (4 questions), (g) Treatment of Family Member with Respect (1 question), (h) Rating of Hospice Care (overall 0-10 scale) + Willingness to Recommend (single question). CAHPS results publicly reported on Care Compare quarterly. Disciplined hospices target top-quartile CAHPS scores which correlate with referral source preference + family + community reputation.

(3) HCI (Hospice Care Index) — 2022+ composite quality index with 10 indicators publicly reported on Care Compare: see audit section above for full list. 2024+ HCI underperformance triggers up to 2% Medicare payment reduction under HQRP value-based payment linkage.

The disciplined hospice operator: builds HQRP/HIS/CAHPS/HCI reporting capability into EMR workflow with automated data capture + automated submission + real-time dashboarding, monitors HIS measures monthly with corrective action for under-performance, monitors CAHPS results quarterly with corrective action for low scores (visit-pattern adjustment + training + family communication improvement), monitors HCI indicators monthly with corrective action for outliers (especially Hospice Visits in Last Days of Life + Gaps in Skilled Nursing Visits + Live Discharge patterns), incorporates HQRP performance into QAPI program + IDT culture + clinical staff incentive compensation.

---

📈 PART 4 — GROWTH & EXIT

Marketing, community education & referral cultivation

Hospice marketing is fundamentally B2B-to-referral-sources (hospital discharge planners + SNF/AL + oncology + cardiology + primary care + community physicians + HHA + faith community) plus secondary B2C-to-families-researching-end-of-life-care. The marketing stack:

(1) Community liaisons / hospice liaison nurses (PRIMARY BD function) — hospice-employed BD reps embedded with referring hospitals + SNF/AL + oncology + cardiology + primary care; daily presence + same-day response + clinical capability + 24/7 admissions accepting + maintained census growth + responsive communication; 5-15 strong referral relationships drive 60-75% of admits.

(2) Physician outreach + CME (Continuing Medical Education) — quarterly CME events for referring physicians on hospice eligibility + Medicare benefit + symptom management + difficult conversation + advance care planning + palliative care to hospice transition; physician relationship cultivation through education builds referrals.

(3) Hospital + SNF + AL chain preferred-provider arrangements — large hospital systems + SNF chains (Genesis, Life Care, PruittHealth, Consulate, Trilogy, CommuniCare, Brookdale AL, Holiday by Atria, Sunrise, Atria, Capital Senior Living) maintain preferred-hospice lists; competitive contract negotiation + quality demonstration earn inclusion.

(4) Palliative care to hospice transition partnerships — formal partnerships with palliative care programs (hospital-based + ambulatory + community palliative) for streamlined hospice transition; growing dominant referral pathway.

(5) Community education + Hospice Awareness Month (November) — community presentations to senior centers + faith communities + civic organizations + Rotary/Kiwanis + caregiver support groups + Area Agency on Aging on hospice services + Medicare benefit + advance care planning + bereavement support; NHPCO promotes National Hospice and Palliative Care Month every November.

(6) Care Compare profile optimization — hospice profile on medicare.gov/care-compare with quality measures (HIS + CAHPS + HCI) + services + ownership + survey history; respond to data accuracy + family reviews.

(7) Website with services + IDT + bereavement + admissions inquiry form + family resources — modern hospice websites support family decision-making + referral source verification + community education.

(8) Google Business Profile + Maps + Google Ads — local search for "[city] hospice" / "hospice care near me" / "end of life care [city]"; Google Ads $6-$18 CPC.

(9) NHPCO membership + state hospice association + AHCA/NCAL — industry association membership + advocacy + networking + education + benchmarking.

(10) Faith-based community outreach — clergy + congregations + faith community nurses + chaplain network referrals + bereavement partnership.

(11) Funeral home + bereavement partnership — funeral home cooperation + community bereavement support + funeral director referrals (occasional pre-need families).

(12) Family reunion + bereavement memorial events — annual memorial services + family reunion + butterfly release + tree planting + virtual memorials; bereavement family contact = future referrals + community ambassadors.

(13) Reputation management — Google/Yelp/Facebook reviews + Care Compare quality measures + family satisfaction surveys; respond to all reviews professionally; address complaints rapidly.

(14) Specialty positioning — pediatric hospice (rare specialty serving children + perinatal), AIDS hospice (legacy 1980s-90s specialty), inner-city / underserved community hospice, faith-based hospice (Catholic + Jewish + denominational), veteran-focused hospice (We Honor Veterans program), LGBTQ+ inclusive hospice, multilingual hospice.

Marketing budget: typical hospice runs 2-4% of revenue on marketing ($160K-$480K annually for stabilized 100-ADC hospice) including community liaisons (often largest line item at $120K-$240K loaded cost per liaison), CRM/admissions software, Google Ads, community engagement, CME events, NHPCO membership, faith community outreach. Census/ADC benchmarks: target stabilized 100-200+ ADC for single-office hospice; scaling to 500-1,500 ADC for multi-office regional hospice; 5,000-50,000+ ADC for multi-state mega platform. ADC growth rate: disciplined hospice grows 15-35% ADC annually in years 1-3 from de novo ramp; 8-15% organic + acquisition growth in mature years.

Scale milestones from 1 office to multi-state platform

Single-office 50-100 ADC hospice: $4M-$10M revenue, 25-45 FTE + contract physician, 8-18% EBITDA margin, $320K-$1.8M EBITDA, founder is hands-on Administrator / Executive Director typically with DPCS + business office; single-office founder profile = manageable regulatory + operational job; lifestyle business or growth platform.

Single-office 100-200 ADC hospice: $8M-$20M revenue, 35-75 FTE + contract physician, 12-22% EBITDA margin, $960K-$4.4M EBITDA; sub-acquisition candidate or scaling regional platform foundation.

Multi-office regional 2-5 offices (200-1,000 ADC): $20M-$100M revenue, 75-300 FTE; founder transitions to regional executive role with office Administrators reporting; shared back-office (HR, accounting, billing, compliance, regulatory affairs, BD, IT, EMR).

Multi-state platform 5-25 offices (1,000-5,000 ADC): $80M-$500M revenue, 300-1,500 FTE; dedicated regional VPs + Chief Clinical Officer + Chief Compliance Officer + Chief Medical Officer (CMO board-certified HPM) + Chief Financial Officer + Chief HR Officer + Chief Information Officer + dedicated regulatory affairs + audit defense + Medicare cap monitoring + PEPPER + HCI optimization; strong sub-acquisition candidate for PE-backed national consolidators or strategic acquirers (Humana CenterWell, Optum, Amedisys, Compassus, Bristol).

National platform 25-200+ offices (5,000-50,000+ ADC): $500M-$3B+ revenue, 1,500-15,000 FTE; VITAS Healthcare / Chemed (NYSE: CHE, ~50,000 ADC, market cap ~$8.5B), Amedisys (NASDAQ: AMED, ~14,000 hospice ADC, Optum acquisition pending), Compassus (Audax + TowerBrook, ~14,000 ADC, Ascension JV), AccentCare (Advent International, ~13,000 hospice ADC), Enhabit (NYSE: EHAB, ~10,000 hospice ADC), Pennant Group (NASDAQ: PNTG, ~5,000 ADC, Ensign spinoff), Bristol Hospice (Webster Equity Partners), Humana CenterWell Hospice (Curo legacy), Aveanna (NASDAQ: AVAH), LHC Group (UnitedHealth/Optum).

Scaling capital: PE growth equity at platform scale (2+ offices or strategic positioning) including healthcare-focused PE (Audax, Vistria Group, Welsh Carson Anderson & Stowe, Clayton Dubilier & Rice, Carlyle Group, KKR, Apollo, Bain Capital, TPG, Webster Equity Partners, Advent International, TowerBrook, Linden Capital Partners, Avista Capital, Centre Partners, Lee Equity Partners, GTCR); strategic acquirers (Optum/UnitedHealth, Humana CenterWell, Aetna/CVS, Ascension Health, AccentCare, Amedisys, Compassus, VITAS Healthcare, Bristol Hospice, Pennant, Enhabit); conventional commercial debt through healthcare lenders (BMO Harris, Capital One Healthcare, Truist Healthcare Banking, KeyBanc, Fifth Third, Regions, MidCap Financial); SBA 7(a) for smaller-scale acquisitions up to $5M; revenue-based financing or factoring for working capital + cap reserve. Hospice is PE-favored vertical because of stable per-diem reimbursement + recession-resistant demand + demographic tailwind + consolidation runway (~5,800 hospices including ~3,500 small independents = consolidation opportunity).

PE/strategic consolidation & exit math

Exit multiples for hospice operating companies in 2025-2026 vary by scale, ADC, payer mix, EBITDA margin, geographic concentration, audit standing, and accreditation. Single-office hospice (50-150 ADC): typically sells at 6-9x EBITDA depending on ADC + payer mix + market position + audit history; 8-10x for stabilized 150+ ADC with clean audit + 4+ stars on Care Compare + balanced LOS mix; 5-7x for sub-100 ADC + audit issues + LOS outliers; distressed/under-100 ADC + audit/CIA + LOS issues at 3-5x or asset-sale-only.

Multi-office regional hospice (200-1,000 ADC): 8-11x EBITDA for stabilized regional hospices with diversified geographic mix + strong quality + balanced payer mix + clean audit. Multi-state platform (1,000-5,000 ADC): 10-13x EBITDA for top-tier regional operators. National platform (5,000-50,000+ ADC): 11-14x EBITDA for top-tier brand operators (Chemed/VITAS trades at ~12-15x reflecting market leadership + consistent execution).

PE consolidators historically active in hospice: Welsh Carson Anderson & Stowe (Curo Health Services 2014, sold to Humana 2018), Audax Group (Compassus + HouseWorks), Vistria Group, Clayton Dubilier & Rice (Humana CenterWell partial 2021), Webster Equity Partners (Bristol Hospice), Advent International (AccentCare), TowerBrook (Compassus), Linden Capital Partners, Avista Capital, Centre Partners, Lee Equity Partners, GTCR, Carlyle Group, KKR, Apollo, Bain Capital, TPG, plus strategic acquirers Optum/UnitedHealth (Amedisys acquisition pending FTC review, LHC Group acquired 2023), Humana CenterWell, Aetna/CVS, Ascension Health (Compassus JV).

Strategic operating company acquirers: VITAS Healthcare / Chemed (active acquirer at premium multiples for fold-in tuck-ins in existing markets), Amedisys / Optum, Compassus, AccentCare, Enhabit, Bristol Hospice, Pennant Group, Humana CenterWell Hospice, regional operators in target geographies.

Exit valuation drivers: (1) ADC scale (larger ADC = higher multiple, 100+ ADC threshold for serious PE attention, 500+ for national PE interest), (2) EBITDA margin (15%+ premium, sub-10% discount, 20%+ rare premium), (3) Quality measures (Care Compare HIS/CAHPS/HCI top-quartile premium, bottom-quartile discount), (4) Audit posture + history (clean PEPPER/UPIC/TPE premium, CIA or active audit deep discount), (5) Length-of-stay mix (balanced 60-90 day average premium, long-stay >150 day average discount, FAST 7C dementia heavy discount), (6) Payer mix (Medicare-dominant 90%+ premium, Medicaid-heavy discount), (7) Geographic concentration (single-state efficiency premium, multi-state platform premium for national PE interest), (8) Accreditation (CHAP/ACHC/TJC current premium, lapsed/issues discount), (9) Referral source concentration (diversified 5-15 sources premium, 1-2 source concentration discount), (10) CON status (CON-state premium for acquired CON moat; non-CON discount on competitive entry exposure), (11) Real estate (typically lease-only operator, no real estate component unless freestanding IPU operated), (12) Founder transition (founder willing to roll equity + 2-3 year earn-out premium).

Counter-case & risks

Covered in detail in the dedicated Counter-Case section below: Medicare audit exposure + qui tam DOJ False Claims Act (DOJ recovered $3B+ 2010-2024, VITAS $75M+, AseraCare $1B initial settlement reversed on appeal, ongoing whistleblower cases under seal), length-of-stay scrutiny + live discharge audit flag, FAST 7C dementia eligibility ambiguity + #1 audit target, PEPPER report comparative analytics + 8 outlier indicators, HCI Hospice Care Index 2024+ underperformance penalties up to 2% Medicare revenue, 17-state CON barrier (NY/NC/GA/TN/KY/WV/VA/MS/AL/SC/MD/DC/CT/RI/ME/VT/NH/HI), RN labor crisis (35-55% turnover + contract agency 2.5-3x premium), referral source dependency (60-75% from 5-15 sources, losing 1-2 collapses census), Medicare Cap (~$35K/patient/year aggregate cap), Medicare Hospice Benefit reform pressure, MA hospice carve-in VBID expired but periodic reform pilots, palliative care upstream displacement, market over-saturation in mature states (FL/AZ/UT/AR), PE/strategic consolidation pressure on small independents, accreditation maintenance burden, family bereavement quality scrutiny via CAHPS.

The Operating Journey: From CMS-855A Application To Stabilized Multi-State Hospice Platform

The Decision Matrix: Format Selection And Operating Model

Sources

1. CMS Hospice Center (cms.gov/medicare/medicare-fee-for-service-payment/hospice) -- Dominant CMS hospice payment + regulatory data source covering per-diem rates (RHC, CHC, IRC, GIP), Medicare Cap, sequential billing, Hospice Quality Reporting Program, Care Compare. https://www.cms.gov/medicare/medicare-fee-for-service-payment/hospice
2. CMS 42 CFR 418 Hospice Conditions of Participation -- Federal regulatory backbone for hospice licensing covering patient rights, IDT, plan of care, QAPI, infection control, core services, volunteer requirements, medical director, hospice aide, emergency preparedness. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-418
3. CMS Medicare Hospice Benefit (Medicare Benefit Policy Manual Chapter 9) -- Comprehensive Medicare Hospice Benefit operational guidance covering eligibility, election, certification, four levels of care, Cap, sequential billing, NOE/NOTR. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Internet-Only-Manuals-IOMs-Items/CMS012673
4. CMS Care Compare Hospice (medicare.gov/care-compare) -- Dominant hospice quality data source with HIS + CAHPS + HCI publicly reported quality measures, ownership data, contact information. https://www.medicare.gov/care-compare/?providerType=Hospice
5. CMS Hospice Quality Reporting Program (HQRP) -- Mandatory quality reporting program under Section 3004 of Affordable Care Act covering HIS Hospice Item Set + CAHPS Hospice Survey + HCI Hospice Care Index with 4% Medicare payment reduction for non-reporting. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Hospice-Quality-Reporting
6. CMS Hospice Item Set (HIS) -- Patient-level data collection at admission + discharge covering 8 admission measures + 1 discharge measure (treatment preferences, beliefs, pain screening, dyspnea, opioid bowel regimen, visits when death imminent). https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Hospice-Quality-Reporting/HIS
7. CMS CAHPS Hospice Survey -- Bereaved-family satisfaction survey administered by CMS-approved CAHPS vendor to family caregivers 2-3 months after patient death. https://www.hospicecahpssurvey.org
8. CMS Hospice Care Index (HCI) -- 2022+ composite quality index with 10 indicators publicly reported on Care Compare measuring service intensity, access, nursing/aide visit patterns, GIP utilization, live discharges, bereavement contact. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Hospice-Quality-Reporting/Hospice-Care-Index-HCI
9. CMS PEPPER (Program for Evaluating Payment Patterns Electronic Report) -- TMF Health Quality Institute-prepared comparative analytics report distributed quarterly to every Medicare hospice with 8 hospice-specific outlier indicators (long LOS, live discharge, nursing facility, CHC+GIP use, single diagnosis, no GIP/CHC). https://www.pepper.cbrpepper.org
10. NHPCO (National Hospice and Palliative Care Organization) -- Dominant hospice industry trade association covering ~4,000+ hospice + palliative care providers with policy advocacy, education, regulatory updates, Facts and Figures report. https://www.nhpco.org
11. MedPAC (Medicare Payment Advisory Commission) -- Independent congressional agency advising Congress on Medicare payment with comprehensive hospice payment + quality data in annual March + June reports. https://www.medpac.gov
12. VITAS Healthcare (Chemed Corporation NYSE: CHE) -- Largest US for-profit hospice ~50,000 ADC across 14 states, market cap ~$8.5B, owned by Chemed which also owns Roto-Rooter. https://www.vitas.com
13. Amedisys (NASDAQ: AMED) -- Optum/UnitedHealth acquisition pending FTC review, ~14,000 hospice ADC + home health platform. https://www.amedisys.com
14. Enhabit (NYSE: EHAB) -- Spun off from Encompass Health 2022, hospice + home health ~10,000 hospice ADC. https://www.ehab.com
15. Compassus -- Audax Group + TowerBrook PE backed, ~14,000 hospice ADC across 30 states with Ascension Health JV. https://www.compassus.com
16. Bristol Hospice -- Webster Equity Partners PE-backed multi-state hospice operator. https://www.bristolhospice.com
17. Pennant Group (NASDAQ: PNTG) -- Ensign Group hospice spinoff with ~5,000 ADC. https://www.pennantgroup.com
18. AccentCare (Advent International) -- PE-backed hospice + home health ~13,000 hospice ADC, acquired Seasons Hospice 2020. https://www.accentcare.com
19. Humana CenterWell Hospice (formerly Curo Health Services) -- Humana acquired 2018 then partial divestiture to Welsh Carson + Clayton Dubilier 2021, hospice service line in Humana CenterWell. https://www.humana.com/centerwell
20. LHC Group (Optum/UnitedHealth) -- Acquired 2023, hospice + home health platform integrated into Optum. https://www.lhcgroup.com
21. Homecare Homebase (Hearst Health) -- Dominant home health + hospice EMR with ~30%+ hospice market share including VITAS, Amedisys, Compassus, Pennant, HouseWorks. https://www.hchb.com
22. MatrixCare (ResMed) Hospice -- Major hospice EMR (also dominant in SNF), full clinical + financial + quality reporting. https://www.matrixcare.com/long-term-care/hospice
23. Enclara Pharmacia (Humana) -- Largest hospice pharmacy nationally serving 35%+ of US hospice ADC. https://www.enclarapharmacia.com
24. Optum Hospice Pharmacy Services (UnitedHealth) -- Second-largest hospice pharmacy. https://www.optum.com
25. Apria Healthcare (Owens & Minor) -- Largest hospice DME provider (hospital bed, oxygen, wheelchair, walker, commode). https://www.apria.com
26. CHAP (Community Health Accreditation Partner) -- Dominant home health + hospice accreditor with CMS-deemed status. https://www.chapinc.org
27. ACHC (Accreditation Commission for Health Care) -- Second-largest home health + hospice accreditor. https://www.achc.org
28. The Joint Commission (TJC) -- Legacy hospital-focused accreditor with hospice program. https://www.jointcommission.org
29. AHCA/NCAL (American Health Care Association) -- SNF + AL + hospice industry trade association covering ~14,000 long-term care providers. https://www.ahcancal.org
30. Hospice and Palliative Nurses Association (HPNA) -- Professional association for hospice nurses with CHPN + CHPNA certification programs. https://advancingexpertcare.org
31. AAHPM (American Academy of Hospice and Palliative Medicine) -- Professional association for HPM physicians with board certification + education. https://aahpm.org
32. DOJ Hospice Fraud Enforcement (justice.gov) -- Department of Justice civil + criminal hospice fraud prosecution recovered $3B+ 2010-2024 with major cases VITAS $75M+, AseraCare $1B (reversed), Halifax $85M, Hospice of Cincinnati $19M. https://www.justice.gov/civil/false-claims-act
33. OIG HHS Hospice Work Plan -- Annual OIG audit priorities for hospice covering length-of-stay, GIP utilization, eligibility documentation, FAST 7C dementia, live discharge. https://oig.hhs.gov/reports-and-publications/workplan
34. BLS 29-1141 Registered Nurses (RN) -- Bureau of Labor Statistics wage data showing RN median wage $75K-$110K with hospice premium $5K-$15K. https://www.bls.gov/oes/current/oes291141.htm
35. BLS 31-1131 Nursing Assistants (CNA / CHPNA hospice aide) -- BLS wage data showing CNA median wage $35K-$48K. https://www.bls.gov/oes/current/oes311131.htm

Numbers

Industry Size And Demand Reality (CMS, NHPCO, MedPAC, US Census)

• US Medicare-certified hospices: ~5,800 per CMS Hospice Provider Data
• US Medicare beneficiaries served by hospice annually: ~1.7M per NHPCO
• Medicare decedents electing hospice: ~51% in 2024 (up from ~22% in 2000)
• US average length of stay (ALOS): 90-95 days per NHPCO Facts and Figures
• US median length of stay: 18 days (long-tail driven by FAST 7C dementia 6-24+ months)
• Top hospice diagnoses: ~30% cancer + ~20% dementia + ~15% cardiac + ~10% pulmonary + ~5% stroke + ~20% other
• 75+ population 2024: ~24M growing to ~45M by 2040 per US Census
• 65+ population 2024: ~58M growing to ~80M by 2040
• State-by-state hospice penetration: 35-65% (Sun Belt FL/AZ/UT/AR high, Northeast NY/MA/NJ low)
• For-profit hospice market share: ~70% in 2024 (up from ~30% in 2000)
• Nonprofit hospice market share: ~30% in 2024
• Hospice in nursing facility (SNF/AL): ~45% of hospice patients reside in SNF or AL
• Hospice at home: ~50% of hospice patients reside in private home
• Hospice in inpatient unit (GIP/IPU): ~1.5% of hospice days
• Hospice provider scale: small <50 ADC, mid <200 ADC, large 200-1,000 ADC, mega 1,000+ ADC
• VITAS Healthcare (Chemed CHE): ~50,000 ADC across 14 states, market cap ~$8.5B
• Amedisys Hospice (Optum acquisition pending): ~14,000 hospice ADC
• Compassus (Audax + TowerBrook): ~14,000 ADC across 30 states with Ascension JV
• AccentCare (Advent International): ~13,000 hospice ADC
• Enhabit (NYSE: EHAB): ~10,000 hospice ADC (Encompass Health spinoff 2022)
• Pennant Group (NASDAQ: PNTG): ~5,000 ADC (Ensign spinoff)
• Hospice of the Valley (Phoenix): ~3,500 ADC (largest US nonprofit)
• CON states: 17 states still operate CON for hospice (NY, NC, GA, TN, KY, WV, VA, MS, AL, SC, MD, DC, CT, RI, ME, VT, NH, HI)
• Non-CON states: ~33 states (CA, TX, FL, AZ, NV, UT, CO, NM, ID, WY, KS, IN, WI, PA, DE, LA, plus others)
• RN turnover (hospice): 35-55% routinely
• Hospice RN wage premium over general RN: $5K-$15K
• 2024 HCI underperformance Medicare payment reduction: up to 2%
• HQRP non-reporting Medicare payment reduction: 4%

Startup Cost Stack By Operator Format

Insurance Stack (Annual Year 1)

Medicare Hospice Per-Diem Rates (FY2025)

Payer Mix Reality

Real Estate And Capital Financing Reality

Cost Stack Per Stabilized 100-ADC Hospice (Mature Year 3, Balanced Payer Mix + Length-Of-Stay)

(NOTE: This base case shows healthy ~20% EBITDA margin reflecting hospice's structural per-diem advantage. Disciplined operators achieving 15-22% EBITDA run at 100+ ADC, Medicare-dominant payer mix, sub-5% contract agency, balanced 60-120 day ALOS, clean audit posture.)

Per-Format Mature Year 3 P&L Summary (100-ADC Hospice)

Five-Year Revenue Trajectory By Format

Operational Benchmarks

• Stabilized ADC target single-office: 100-200 ADC (industry small <50 / mid <200 / large 200-1,000)
• ADC growth rate de novo years 1-3: 15-35% annually
• ADC growth rate mature: 8-15% organic + acquisition
• Target payer mix: 88-94% Medicare + 3-8% Medicaid + 1-3% commercial
• RN case manager ratio: 1:12-1:15 (per CMS guidance)
• Hospice aide ratio: 1:8-1:12 patients (3-5 visits/week per patient)
• MSW ratio: 1:35-1:50
• Chaplain ratio: 1:50-1:75
• Volunteer hours requirement per CoP §418.78: ≥5% of total patient care hours
• ALOS target: 60-120 days (US average 90-95 days)
• Median LOS target: 14-30 days (US median 18 days)
• Long-stay LOS > 180 days target: <20% (PEPPER outlier flag at 80th+ percentile)
• Long-stay LOS > 365 days target: <10%
• Live discharge % target: <12-18%
• FAST 7C dementia % target: <35% (audit attention if higher)
• GIP utilization target: 1-3% of total patient days (PEPPER flag if too high or too low)
• CHC utilization target: 0.1-0.5% of total patient days
• IRC utilization target: 0.2-0.5% of total patient days
• Medicare Cap utilization target: 85-95% (avoid overage repayment)
• RN turnover target: 25-35% (industry 35-55%)
• Hospice aide turnover target: 25-35% (industry 40-60%)
• Contract agency target: <5% of nursing labor
• Hospice RN wage: $80K-$120K (BLS 29-1141 + $5K-$15K hospice premium)
• Hospice NP wage: $115K-$155K (BLS 29-1171)
• Hospice MSW wage: $58K-$78K (BLS 21-1022)
• Hospice chaplain wage: $48K-$72K
• Hospice aide / CHPNA wage: $35K-$48K (BLS 31-1131)
• Hospice Medical Director (HMD) compensation: $185K-$385K annualized (0.5 FTE typical 100 ADC)
• Administrator / Executive Director wage: $95K-$175K (BLS 11-9111)
• DPCS (Director of Patient Care Services, RN): $105K-$155K
• Workers Comp NCCI 8826 rate: $2.50-$6.50 per $100 payroll
• Insurance load Year 1 100-ADC: $150K-$650K
• Marketing budget % of revenue: 2-4%
• Google Ads CPC hospice keywords: $6-$18
• CAHPS family satisfaction target: top-quartile on Care Compare
• HCI top-quartile target: 8-10 of 10 indicators
• HQRP non-reporting penalty: 4% Medicare payment reduction
• HCI underperformance penalty (2024+): up to 2% Medicare payment reduction
• DOJ hospice FCA recovery 2010-2024: $3B+
• VITAS / Chemed cumulative DOJ settlements: $75M+
• AseraCare initial settlement (reversed on appeal 2019): $1B
• Halifax Hospice settlement: $85M
• Hospice of Cincinnati settlement: $19M
• Operating business EBITDA multiple single-office hospice: 6-9x (8-10x for stabilized 150+ ADC, 5-7x sub-100 ADC)
• Operating business EBITDA multiple regional 200-1,000 ADC: 8-11x
• Operating business EBITDA multiple multi-state 1,000-5,000 ADC: 10-13x
• Operating business EBITDA multiple national 5,000-50,000+ ADC: 11-14x
• VITAS / Chemed public multiple: ~12-15x (best-in-class)

Local Regulatory Reality (Top Hospice States)

Exit Multiples By Format

Strategic Acquirers

• VITAS Healthcare / Chemed (NYSE: CHE) -- ~50,000 ADC, largest US for-profit hospice, active acquirer fold-in tuck-ins
• Amedisys (NASDAQ: AMED) -- Optum/UnitedHealth acquisition pending FTC review, ~14,000 hospice ADC
• Compassus (Audax + TowerBrook) -- ~14,000 ADC across 30 states with Ascension JV
• AccentCare (Advent International) -- ~13,000 hospice ADC, acquired Seasons Hospice 2020
• Enhabit (NYSE: EHAB) -- ~10,000 hospice ADC, Encompass spinoff 2022
• Pennant Group (NASDAQ: PNTG) -- ~5,000 ADC, Ensign spinoff
• Bristol Hospice (Webster Equity Partners) -- Multi-state regional consolidator
• Humana CenterWell Hospice (Curo legacy) -- Humana 2018 acquisition + partial Welsh Carson + CD&R divest 2021
• LHC Group (Optum/UnitedHealth) -- Acquired 2023, hospice + home health integrated
• Aveanna Healthcare (NASDAQ: AVAH) -- Home health + hospice + private duty
• Welsh Carson Anderson & Stowe -- Healthcare PE (former Curo sponsor)
• Audax Group -- PE consolidator (Compassus, HouseWorks)
• Vistria Group -- Healthcare PE
• Clayton Dubilier & Rice (CD&R) -- Humana CenterWell partial 2021
• Webster Equity Partners -- PE sponsor (Bristol Hospice)
• Advent International -- PE sponsor (AccentCare)
• TowerBrook Capital Partners -- PE sponsor (Compassus)
• Linden Capital Partners -- Healthcare PE
• Avista Capital -- Healthcare PE
• GTCR -- PE
• KKR -- Mega PE
• Apollo Global Management -- Mega PE
• Bain Capital -- Mega PE
• Carlyle Group -- Mega PE
• Optum / UnitedHealth Group (NYSE: UNH) -- Strategic insurance + senior services integrator (Amedisys + LHC)
• Humana CenterWell (NYSE: HUM) -- Strategic insurance + senior services integrator
• Aetna / CVS Health (NYSE: CVS) -- Strategic insurance integrator
• Ascension Health -- Catholic health system (Compassus JV)

Counter-Case: Why Starting A Hospice Care Agency Business In 2027 Might Be A Mistake

A serious founder must stress-test the case above against the conditions that make this model a bad bet.

Counter 1 — Medicare audit + qui tam DOJ False Claims Act exposure is existential. DOJ recovered $3B+ in hospice False Claims Act settlements 2010-2024 including VITAS Healthcare $75M+ cumulative, AseraCare $1B initial settlement (reversed on 11th Circuit appeal 2019 but chilling effect persists), Halifax Hospice $85M, Hospice of Cincinnati $19M, SouthernCare Inc $24.7M, Hospice Plus / Curo $12.2M, plus dozens of smaller $2M-$20M settlements + ongoing under-seal qui tam cases by whistleblowers (former employees + nurses + physicians) with potential 15-30% relator share driving plaintiff bar interest. Federal audit apparatus includes UPIC (Unified Program Integrity Contractor) + ZPIC + TPE (Targeted Probe and Educate) + RAC (Recovery Audit Contractor) + OIG (Office of Inspector General) + DOJ + qui tam False Claims Act. Sophisticated hospices must operate with audit-ready compliance posture as the highest operating priority — single qui tam case can produce $5M-$100M+ DOJ settlement + Corporate Integrity Agreement (CIA) + Medicare termination + reputation damage.

Counter 2 — Length-of-stay scrutiny + PEPPER report comparative analytics flag outlier operators for audit. PEPPER (Program for Evaluating Payment Patterns Electronic Report) distributed quarterly to every Medicare hospice via CMS portal compares each hospice's percentiles vs national/state peers on 8 hospice-specific outlier indicators: long LOS > 180 days, long LOS > 365 days, live discharge for non-patient-decision reasons, live discharge general, hospice in nursing facility, CHC+GIP utilization, single diagnosis (FAST 7C dementia/debility/FTT), no GIP/CHC. Hospices in 80th+ percentile (or 20th percentile for under-utilization) face elevated audit risk + recommended internal review + potential UPIC referral. Disciplined hospices monitor PEPPER quarterly with corrective action for outlier indicators — undisciplined hospices treat PEPPER as ignorable until UPIC audit arrives.

Counter 3 — FAST 7C dementia eligibility ambiguity + #1 audit target. FAST (Functional Assessment Staging Tool) Stage 7C is the Medicare hospice eligibility threshold for Alzheimer's / dementia (defined as: progression to FAST 7 + speech limited to ≤6 intelligible words/day + non-ambulatory + dependent in all ADLs + plus secondary conditions like recurrent UTI, recurrent aspiration pneumonia, weight loss, decubitus ulcer, recurrent ED visits). FAST 7C is clinically ambiguous + subject to disagreement among physicians + the dominant audit target because dementia patients can survive 12-36+ months in FAST 7C (challenging the 6-month prognosis threshold). Operators with high dementia % face elevated audit attention; AseraCare $1B case was largely FAST 7C eligibility dispute. Sophisticated hospices document objective FAST 7C criteria + secondary conditions + clinical judgment + recertification F2F documentation with extreme care.

Counter 4 — 17-state CON barrier limits market entry. 17 states still operate Certificate of Need (CON) for hospice including NY, NC, GA, TN, KY, WV, VA, MS, AL, SC, MD, DC, CT, RI, ME, VT, NH, HI. CON application $15K-$125K + 6-18 month review + public hearings + competing applications + 25-55% success rate makes de novo CON-state entry impractical for most founders. Acquisition of existing licensed hospice (CHOW) at $1.5M-$8M is the practical entry path in CON states — but acquisition multiples increasingly competitive as PE consolidators bid up CON-state targets. Operators in non-CON states (CA, TX, FL, AZ, NV, UT, CO, NM, ID, WY, KS, IN, WI, PA, DE, LA, plus others) face easier entry but more competitive market with 8-25+ hospices competing for referrals.

Counter 5 — RN labor crisis + 35-55% turnover + contract agency 2.5-3x premium. Hospice RN turnover 35-55% routinely with contract agency RN/NP/HHA at $85-$135/hour vs $80-$120K core wage (2.5-3x premium). Agency use varies dramatically by market (urban tight markets 8-18% of nursing labor, mid-market 3-8%, rural 1-5%). The 2024 CMS hospice payment update + ongoing labor pressure + competing senior care demand for RNs (SNF + HHA + AL + hospital + clinic + Medicare Advantage care management) keeps wage inflation high. Disciplined hospices focus on RN pipeline + retention (sign-on bonuses $5K-$15K, retention bonuses $2K-$10K, predictable visit-based scheduling, hospice-experience premium $5K-$15K above general RN, career ladder to NP + DPCS, CHPN certification investment, RN-on-call differential, leadership presence + IDT culture) to reduce turnover toward 25-35% (still high but better than 55%+).

Counter 6 — Referral source dependency creates concentration risk. 60-75% of hospice admissions flow through 5-15 referral sources (hospital discharge planners + palliative care + SNF/AL/MC administrators + oncologists + cardiologists + nephrologists + pulmonologists + primary care physicians + HHA + community organizations). Losing 1-2 major referral sources can collapse census within 30-60 days — particularly devastating when a competing hospice steals a hospital system contract or SNF chain preferred-hospice arrangement. Disciplined hospices diversify referral pipeline + cultivate 15-30 active referral sources + invest heavily in community liaisons + maintain 24/7 admission capability + clinical excellence demonstrable via Care Compare quality measures + responsive same-day service to reduce concentration risk.

Counter 7 — HCI 2024+ Medicare payment reduction + HQRP penalty exposure. 2024+ HCI (Hospice Care Index) underperformance triggers up to 2% Medicare payment reduction under HQRP value-based payment linkage; HQRP non-reporting triggers 4% Medicare payment reduction. HCI 10 indicators include hospice visits in last days of life, gaps in skilled nursing visits, live discharges, burdensome transitions, per-beneficiary Medicare spending, skilled nursing care minutes per RHC day, skilled nursing minutes on weekends. Operators with inadequate visit intensity in last days of life + frequent live discharges + irregular visit patterns + low skilled nursing minutes face structural Medicare payment penalty on top of competitive disadvantage. Disciplined hospices invest in HCI optimization + HQRP automation + EMR-integrated quality dashboards.

Counter 8 — Medicare Hospice Cap (~$35K/patient/year) constrains long-stay operators. FY2025 cap is $34,465.34 per patient per year aggregate. Hospices exceeding cap must repay overage to CMS via annual cap reconciliation (settled 12-18 months after cap year end). Dementia-heavy operators (FAST 7C dementia patients with 12-36+ month LOS) can push hospices into cap overage if dementia % too high without offsetting short-stay patients. Disciplined hospices monitor cap utilization in real-time + adjust admission mix to balance long-stay + short-stay patients keeping cap utilization at 85-95%. Cap overage repayments can be devastating to cash flow for under-capitalized operators.

Counter 9 — Medicare Hospice Benefit reform pressure + ongoing payment scrutiny. Medicare Hospice Benefit has been subject to ongoing reform proposals including RHC U-shape rate structure (implemented 2016 reducing day 61+ rates), Service Intensity Add-on (implemented 2016), CHC + GIP audit scrutiny (ongoing), HQRP + HCI + value-based payment linkage (2022+), aggregate cap (since 1983), VBID hospice carve-in pilot (2021-2024 expired). Future reform pressure includes potential rate cuts, audit intensification, cap restructuring, MA hospice carve-in revival, value-based payment expansion all of which can compress operator margins. Operators must plan for continued payment scrutiny + audit intensification + quality measure expansion.

Counter 10 — Palliative care upstream displacement + market over-saturation in mature states. Palliative care is growing rapidly as upstream "bridge to hospice" service delivered by hospital + ambulatory + community palliative programs — capturing patients earlier in serious illness trajectory who may delay hospice election or bypass hospice entirely through palliative-only care. Mature hospice markets (FL, AZ, UT, AR, CA, TX) have 55-65% hospice penetration + 8-25+ hospices competing for referrals = over-saturated competition + slower growth. Operators entering mature markets face higher BD investment + lower admit-per-referral conversion + price/quality competition. New entrants should evaluate market saturation via CMS Hospice Compare + state penetration data + competitive analysis.

Counter 11 — PE/strategic consolidation pressure on small independents. PE-backed consolidators (Audax + Vistria + Welsh Carson + Webster + Advent + TowerBrook + Clayton Dubilier) + strategic acquirers (Optum/UnitedHealth, Humana CenterWell, AccentCare, Amedisys, Compassus, Bristol, Pennant, VITAS, Enhabit) negotiate bulk insurance pricing 15-25% below single-operator rates, bulk pharmacy + DME contracts, bulk EMR licensing, professional regulatory + clinical + audit defense operations, shared back-office economics. Single-office independent hospices face 3-7% margin disadvantage vs consolidator competition in shared markets. The disciplined small operator either positions for early acquisition by PE-backed consolidator or strategic (typically 4-7 years into stabilized operations at 6-9x EBITDA) OR specializes in clinical niche (pediatric hospice, AIDS hospice, faith-based, LGBTQ+ inclusive, multilingual) OR commits to single-office owner-operator lifestyle business at $320K-$4.4M EBITDA.

Counter 12 — Adjacent senior care + post-acute formats may fit better for founders attracted to senior services but not hospice audit/regulatory intensity. Palliative care (q9620 adjacent — non-terminal symptom management billed Part B physician fees, less per-diem audit risk, growing rapidly); Home health agency HHA (q9630 — Medicare-certified skilled home care, intermittent visit-based PDGM, similar referral pipeline but different audit + cap profile); Non-medical home care NMHHA (private duty caregivers, no Medicare, lower regulation, lower lawsuit exposure, ~$32-$45/hour billing); Assisted living AL (q9650 — state-licensed senior residential, private pay $4,800-$8,500/month, no Medicare cert, lighter regulation); Memory care MC (q9653 — dementia-specialized AL); Adult day care ADC (q9652 — daytime program $85-$185/day); SNF (q9655 — residential 24/7 RN, much higher capital + regulation but Medicare Part A short-stay profit); PACE (Program of All-Inclusive Care for the Elderly — Medicare/Medicaid integrated for nursing-home-eligible at home); CCRC (Continuing Care Retirement Community — integrated IL+AL+MC+SNF); geriatric care management (RN-led care coordination services, fee-for-service, no Medicare); senior placement agency (A Place for Mom franchise) — referral services; senior real estate specialist SRES — real estate broker niche; bereavement counseling private practice — counseling services adjacent to hospice bereavement; funeral home / pre-need services — different industry adjacent to end-of-life. For founders attracted to healthcare with growth potential the question reroutes to palliative care, HHA, NMHHA, AL/MC, PACE, geriatric care management which share demographic tailwind but with different regulatory + audit + reimbursement profiles.

The honest verdict. Starting a hospice care agency business in 2027 is a reasonable choice for a founder who: (a) has matched capital to format ($185K-$485K de novo non-CON, $485K-$1.5M de novo CON-state, $1.5M-$8M CHOW acquisition, $5M-$50M multi-office PE-backed rollup, $235K-$685K + system commitment for health-system JV); (b) has secured CON approval (in 17 CON states) or chosen non-CON state, state DOH hospice license, CMS-855A Medicare hospice provider enrollment, CHAP/ACHC/TJC accreditation, initial CMS certification survey at 6-month mark validating 42 CFR 418 CoP compliance, HIPAA compliance, healthcare regulatory counsel before opening; (c) has built professional liability + GL $1M/$3M minimum (preferably $2M/$5M-$3M/$10M), Workers Comp NCCI 8826, non-owned auto, property, cyber, EPLI, umbrella $5M-$25M, sexual abuse sub-limit, crime, D&O, pollution, bond/surety insurance stack at $150K-$650K annual for single 100-ADC hospice; (d) has chosen sub-market with adequate Medicare beneficiary density (25K-65K Medicare beneficiaries in 30-45 minute drive radius), hospital + SNF + AL discharge volume (3-8 acute care hospitals + 15-30 SNFs + 25-60 AL/MC facilities), competitive hospice landscape analysis via CMS Hospice Compare + state DOH list, state CON status, Medicaid hospice rate environment, labor market viability validated through CMS Hospice Compare + Census + state hospital association + NHPCO data; (e) has built referral pipeline (5-15 active referral sources cultivated via community liaisons / hospice liaison nurses with daily presence + same-day response + clinical capability + 24/7 admissions accepting + maintained census growth), IDT staffing per 42 CFR 418 CoP (Administrator + DPCS RN + HMD physician + RN case managers 1:12-1:15 + 24/7 on-call RN + LPN/LVN + hospice aides CHPNA + MSW + chaplain + bereavement coordinator + volunteer coordinator + NP for F2F recertification), audit-ready compliance posture (Medicare cap monitoring + PEPPER quarterly review + HCI optimization + length-of-stay discipline + FAST 7C documentation + QAPI + internal medical record audit + OIG exclusion list screening + whistleblower hotline), HQRP/HIS/CAHPS/HCI reporting capability automated via EMR, length-of-stay discipline (target ALOS 60-120 days + median LOS 14-30 days + long-stay >180 days <20% + long-stay >365 days <10% + live discharge <12-18% + FAST 7C dementia <35%), Medicare Cap discipline (target 85-95% cap utilization avoiding overage repayment), accreditation maintenance (CHAP/ACHC/TJC 3-year cycle + interim self-assessment), RN pipeline + retention reducing turnover from 55%+ toward 25-35%, contract agency reduction to under 5%, plaintiff lawsuit defense + specialized hospice defense counsel + insurance carrier relationships; (f) has 18-30 months operating reserve to absorb pre-stabilization burn at 50-100 ADC ramp with 12-24 month stabilization, and explicit Medicare audit + qui tam False Claims Act + PEPPER + HCI monitoring discipline as highest operating priority. It is a poor choice for anyone underestimating Medicare audit exposure (DOJ recovered $3B+ + ongoing qui tam under seal), anyone treating it as a "growing demographic tailwind business" rather than highly-regulated Medicare-dependent clinical operating business, anyone unwilling to invest in compliance + audit-ready posture + length-of-stay discipline + FAST 7C documentation, anyone underinvested in community liaison + referral source cultivation, anyone ignoring PEPPER + HCI quality measures, anyone undercapitalized for the 12-24 month de novo certification + census ramp, anyone unable to navigate dual federal CMS + state DOH + accreditation regulatory complexity + CON + CHOW process, anyone whose target state is CON-restricted without local political relationships or acquisition capital, anyone targeting dementia-heavy mix without cap monitoring + length-of-stay discipline, and anyone whose real interest would be better served by palliative care / HHA / NMHHA / AL/MC / PACE / SNF / geriatric care management / bereavement counseling adjacent formats. The model is not a scam, but it is more Medicare-audit-exposed, more qui tam DOJ-targeted, more length-of-stay-scrutinized, more PEPPER + HCI quality-measured, more referral-source-dependent, more CON-restricted (in 17 states), more RN-labor-pressured, more cap-constrained, and more pre-stabilization-fragile than its "aging demographic tailwind" surface suggests — and in 2027 the gap between the disciplined version that works and the audit-naive, length-of-stay-careless, FAST-7C-undocumented version that fails is wide.

Related Pulse Library Entries

• q1127
• q1139
• q1942
• q1946
• q1947
• q1948
• q1949
• q1951
• q1952
• q1953
• q1954
• q1962
• q1965
• q1966
• q1975
• q2117
• q9576
• q9601
• q9620
• q9628
• q9629
• q9630
• q9650
• q9652
• q9653
• q9655